Advanced Search (OLGA)

Gene: CPD (carboxypeptidase D) Homo sapiens

Subscribe to Updates

Analyze

Symbol:

CPD

Name:

carboxypeptidase D

RGD ID:

731463

HGNC Page

HGNC:2301

Description:

Predicted to enable metallocarboxypeptidase activity. Predicted to be involved in peptide metabolic process and protein processing. Located in extracellular exosome and membrane.

Type:

protein-coding

RefSeq Status:

REVIEWED

Previously known as:

GP180; metallocarboxypeptidase D

RGD Orthologs

Alliance Orthologs

More Info

more info ...

More Info

Species	Gene symbol and name	Data Source	Assertion derived from	less info ...
Orthologs ¹				less info ...
Mus musculus (house mouse):	Cpd (carboxypeptidase D)	HGNC	EggNOG, Ensembl, HGNC, HomoloGene, Inparanoid, NCBI, OMA, OrthoDB, OrthoMCL, Panther, Treefam
Rattus norvegicus (Norway rat):	Cpd (carboxypeptidase D)	HGNC	EggNOG, Ensembl, HomoloGene, Inparanoid, NCBI, OMA, OrthoDB, OrthoMCL, Panther, Treefam
Chinchilla lanigera (long-tailed chinchilla):	Cpd (carboxypeptidase D)	NCBI	Ortholog
Pan paniscus (bonobo/pygmy chimpanzee):	CPD (carboxypeptidase D)	NCBI	Ortholog
Canis lupus familiaris (dog):	CPD (carboxypeptidase D)	HGNC	EggNOG, Ensembl, HomoloGene, Inparanoid, NCBI, OMA, OrthoDB, OrthoMCL, Panther, Treefam
Ictidomys tridecemlineatus (thirteen-lined ground squirrel):	Cpd (carboxypeptidase D)	NCBI	Ortholog
Sus scrofa (pig):	CPD (carboxypeptidase D)	HGNC	EggNOG, Ensembl, Inparanoid, NCBI, OMA, OrthoDB, Panther, Treefam
Chlorocebus sabaeus (green monkey):	CPD (carboxypeptidase D)	NCBI	Ortholog
Heterocephalus glaber (naked mole-rat):	Cpd (carboxypeptidase D)	NCBI	Ortholog
Other homologs ²
Rattus norvegicus (Norway rat):	Vom1r35 (vomeronasal 1 receptor 35)	HGNC	OMA
Alliance orthologs ³
Rattus norvegicus (Norway rat):	Cpd (carboxypeptidase D)	Alliance	DIOPT (Ensembl Compara\|HGNC\|Hieranoid\|InParanoid\|OMA\|OrthoFinder\|OrthoInspector\|PANTHER\|PhylomeDB\|SonicParanoid)
Mus musculus (house mouse):	Cpd (carboxypeptidase D)	Alliance	DIOPT (Ensembl Compara\|HGNC\|Hieranoid\|InParanoid\|OMA\|OrthoFinder\|OrthoInspector\|PANTHER\|PhylomeDB\|SonicParanoid)
Danio rerio (zebrafish):	cpdb (carboxypeptidase D, b)	Alliance	DIOPT (Ensembl Compara\|OrthoFinder\|PANTHER\|ZFIN)
Danio rerio (zebrafish):	cpda (carboxypeptidase D, a)	Alliance	DIOPT (Ensembl Compara\|Hieranoid\|InParanoid\|OMA\|OrthoFinder\|OrthoInspector\|PANTHER\|SonicParanoid\|ZFIN)
Caenorhabditis elegans (roundworm):	cpd-1	Alliance	DIOPT (Ensembl Compara\|InParanoid\|OrthoInspector\|SonicParanoid)
Drosophila melanogaster (fruit fly):	svr	Alliance	DIOPT (Ensembl Compara\|Hieranoid\|InParanoid\|OrthoFinder\|OrthoInspector\|PhylomeDB\|SonicParanoid)

Related Pseudogenes:

CPDP1

Allele / Splice:

See ClinVar data

Latest Assembly:

GRCh38 - Human Genome Assembly GRCh38

Position:

Human Assembly	Chr	Position (strand)	Source	Genome Browsers
Human Assembly	Chr	Position (strand)	Source	JBrowse	NCBI	UCSC	Ensembl
GRCh38	17	30,378,927 - 30,469,989 (+)	NCBI	GRCh38	GRCh38	hg38	GRCh38
GRCh38.p14 Ensembl	17	30,378,927 - 30,469,989 (+)	Ensembl	GRCh38		hg38	GRCh38
GRCh37	17	28,705,945 - 28,797,007 (+)	NCBI	GRCh37	GRCh37	hg19	GRCh37
Build 36	17	25,730,110 - 25,819,825 (+)	NCBI	NCBI36	Build 36	hg18	NCBI36
Build 34	17	25,730,109 - 25,819,825	NCBI
Celera	17	25,567,489 - 25,657,199 (+)	NCBI		Celera
Cytogenetic Map	17	q11.2	NCBI
HuRef	17	24,915,981 - 25,006,704 (+)	NCBI		HuRef
CHM1_1	17	28,768,174 - 28,859,153 (+)	NCBI		CHM1_1
T2T-CHM13v2.0	17	31,323,558 - 31,414,615 (+)	NCBI		T2T-CHM13v2.0

JBrowse:

View Region in Genome Browser (JBrowse)

Model

Object Symbol	Species	Term	Qualifier	Evidence	With	Reference	Notes	Source	Original Reference(s)
CPD	Human	neurofibromatosis 1		IAGP	(Homo sapiens) and (Homo sapiens)	8554872	ClinVar Annotator: match by term: Neurofibromatosis and type 1	ClinVar	PMID:10712197 more ...

Only show annotations with direct experimental evidence (0 objects hidden)

Object Symbol	Species	Term	Qualifier	Evidence	With	Reference	Notes	Source	Original Reference(s)
CPD	Human	1,1,1-trichloroethane	decreases expression	ISO	Cpd (Mus musculus)	6480464	1 more ...	CTD	PMID:25270620
CPD	Human	1,1-dichloroethene	increases expression	ISO	Cpd (Mus musculus)	6480464	vinylidene chloride results in increased expression of CPD mRNA	CTD	PMID:26682919
CPD	Human	1,2-dichloroethane	decreases expression	ISO	Cpd (Mus musculus)	6480464	ethylene dichloride results in decreased expression of CPD mRNA	CTD	PMID:28189721 and PMID:28960355
CPD	Human	1,2-dimethylhydrazine	decreases expression	ISO	Cpd (Mus musculus)	6480464	1 and 2-Dimethylhydrazine results in decreased expression of CPD mRNA	CTD	PMID:22206623
CPD	Human	17alpha-ethynylestradiol	increases expression	ISO	Cpd (Mus musculus)	6480464	Ethinyl Estradiol results in increased expression of CPD mRNA	CTD	PMID:17942748
CPD	Human	17alpha-ethynylestradiol	increases expression	ISO	Cpd (Rattus norvegicus)	6480464	Ethinyl Estradiol results in increased expression of CPD mRNA	CTD	PMID:29097150
CPD	Human	17alpha-ethynylestradiol	multiple interactions	ISO	Cpd (Mus musculus)	6480464	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of CPD mRNA	CTD	PMID:17942748
CPD	Human	17beta-estradiol	multiple interactions	ISO	Cpd (Rattus norvegicus)	6480464	[bisphenol A co-treated with Estradiol] results in increased expression of CPD mRNA and [Estradiol co-treated with Testosterone] results in increased expression of CPD mRNA	CTD	PMID:11375906 and PMID:26496021
CPD	Human	17beta-estradiol	increases expression	ISO	Cpd (Mus musculus)	6480464	Estradiol results in increased expression of CPD mRNA	CTD	PMID:39298647
CPD	Human	17beta-estradiol	affects expression	ISO	Cpd (Rattus norvegicus)	6480464	Estradiol affects the expression of CPD mRNA	CTD	PMID:32145629
CPD	Human	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	Cpd (Mus musculus)	6480464	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of CPD mRNA	CTD	PMID:17942748
CPD	Human	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	Cpd (Rattus norvegicus)	6480464	Tetrachlorodibenzodioxin affects the expression of CPD mRNA	CTD	PMID:34747641
CPD	Human	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	Cpd (Rattus norvegicus)	6480464	Tetrachlorodibenzodioxin results in increased expression of CPD mRNA	CTD	PMID:32109520
CPD	Human	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	Cpd (Rattus norvegicus)	6480464	Tetrachlorodibenzodioxin results in decreased expression of CPD mRNA	CTD	PMID:16054898 and PMID:33387578
CPD	Human	2-hydroxypropanoic acid	increases expression	EXP		6480464	Lactic Acid results in increased expression of CPD mRNA	CTD	PMID:30851411
CPD	Human	3,4-methylenedioxymethamphetamine	decreases expression	ISO	Cpd (Rattus norvegicus)	6480464	N-Methyl-3 and 4-methylenedioxyamphetamine results in decreased expression of CPD mRNA	CTD	PMID:30071829
CPD	Human	4,4'-sulfonyldiphenol	decreases expression	ISO	Cpd (Mus musculus)	6480464	bisphenol S results in decreased expression of CPD mRNA	CTD	PMID:39298647
CPD	Human	4,4'-sulfonyldiphenol	affects expression	EXP		6480464	bisphenol S affects the expression of CPD protein	CTD	PMID:31945527
CPD	Human	5-fluorouracil	affects response to substance	EXP		6480464	CPD protein affects the susceptibility to Fluorouracil	CTD	PMID:16217747
CPD	Human	5-fluorouracil	multiple interactions	EXP		6480464	TP53 protein affects the reaction [Fluorouracil results in decreased expression of CPD mRNA]	CTD	PMID:15016801
CPD	Human	6-propyl-2-thiouracil	decreases expression	ISO	Cpd (Rattus norvegicus)	6480464	Propylthiouracil results in decreased expression of CPD mRNA	CTD	PMID:24780913
CPD	Human	aflatoxin B1	affects expression	EXP		6480464	Aflatoxin B1 affects the expression of CPD protein	CTD	PMID:20106945
CPD	Human	aflatoxin B1	decreases methylation	EXP		6480464	Aflatoxin B1 results in decreased methylation of CPD gene	CTD	PMID:27153756
CPD	Human	all-trans-retinoic acid	increases expression	EXP		6480464	Tretinoin results in increased expression of CPD mRNA	CTD	PMID:33167477
CPD	Human	ammonium chloride	affects expression	ISO	Cpd (Rattus norvegicus)	6480464	Ammonium Chloride affects the expression of CPD mRNA	CTD	PMID:16483693
CPD	Human	amphotericin B	decreases expression	EXP		6480464	Amphotericin B analog results in decreased expression of CPD mRNA	CTD	PMID:28534445
CPD	Human	arsane	multiple interactions	EXP		6480464	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of CPD mRNA	CTD	PMID:39836092
CPD	Human	arsenic atom	multiple interactions	EXP		6480464	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of CPD mRNA	CTD	PMID:39836092
CPD	Human	benzo[a]pyrene	decreases expression	ISO	Cpd (Mus musculus)	6480464	Benzo(a)pyrene results in decreased expression of CPD mRNA	CTD	PMID:22228805
CPD	Human	benzo[a]pyrene	affects methylation	EXP		6480464	Benzo(a)pyrene affects the methylation of CPD promoter	CTD	PMID:27901495
CPD	Human	bilirubin IXalpha	decreases expression	EXP		6480464	Bilirubin results in decreased expression of CPD mRNA	CTD	PMID:20196124
CPD	Human	bisphenol A	multiple interactions	ISO	Cpd (Rattus norvegicus)	6480464	[bisphenol A co-treated with Estradiol] results in increased expression of CPD mRNA	CTD	PMID:26496021
CPD	Human	bisphenol A	affects expression	ISO	Cpd (Rattus norvegicus)	6480464	bisphenol A affects the expression of CPD mRNA	CTD	PMID:32145629
CPD	Human	bisphenol A	decreases expression	ISO	Cpd (Rattus norvegicus)	6480464	bisphenol A results in decreased expression of CPD mRNA	CTD	PMID:30816183 and PMID:34947998
CPD	Human	bisphenol A	increases expression	EXP		6480464	bisphenol A results in increased expression of CPD mRNA	CTD	PMID:29275510 and PMID:36232920
CPD	Human	bisphenol A	increases expression	ISO	Cpd (Rattus norvegicus)	6480464	bisphenol A results in increased expression of CPD mRNA	CTD	PMID:25181051 and PMID:29097150
CPD	Human	butan-1-ol	multiple interactions	EXP		6480464	[[Gasoline co-treated with 1-Butanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of CPD mRNA	CTD	PMID:29432896
CPD	Human	butanal	decreases expression	EXP		6480464	butyraldehyde results in decreased expression of CPD mRNA	CTD	PMID:26079696
CPD	Human	caffeine	affects phosphorylation	EXP		6480464	Caffeine affects the phosphorylation of CPD protein	CTD	PMID:35688186
CPD	Human	calcitriol	increases expression	EXP		6480464	Calcitriol results in increased expression of CPD mRNA	CTD	PMID:16002434
CPD	Human	cannabidiol	multiple interactions	ISO	Cpd (Mus musculus)	6480464	[lipopolysaccharide and E coli O55-B5 co-treated with Cannabidiol] results in decreased expression of CPD mRNA	CTD	PMID:30742662
CPD	Human	CGP 52608	multiple interactions	EXP		6480464	CGP 52608 promotes the reaction [RORA protein binds to CPD gene]	CTD	PMID:28238834
CPD	Human	chloropicrin	increases expression	EXP		6480464	chloropicrin results in increased expression of CPD mRNA	CTD	PMID:26352163
CPD	Human	chloroprene	increases expression	ISO	Cpd (Rattus norvegicus)	6480464	Chloroprene results in increased expression of CPD mRNA	CTD	PMID:23125180
CPD	Human	choline	multiple interactions	ISO	Cpd (Mus musculus)	6480464	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of CPD gene	CTD	PMID:20938992
CPD	Human	clorgyline	increases expression	EXP		6480464	Clorgyline results in increased expression of CPD mRNA	CTD	PMID:19691856
CPD	Human	copper atom	multiple interactions	ISO	Cpd (Mus musculus)	6480464	[ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of CPD mRNA	CTD	PMID:15467011
CPD	Human	copper(0)	multiple interactions	ISO	Cpd (Mus musculus)	6480464	[ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of CPD mRNA	CTD	PMID:15467011
CPD	Human	cyclosporin A	decreases expression	EXP		6480464	Cyclosporine results in decreased expression of CPD mRNA	CTD	PMID:25562108
CPD	Human	Dibutyl phosphate	affects expression	EXP		6480464	di-n-butylphosphoric acid affects the expression of CPD mRNA	CTD	PMID:37042841
CPD	Human	dibutyl phthalate	increases expression	ISO	Cpd (Mus musculus)	6480464	Dibutyl Phthalate results in increased expression of CPD mRNA	CTD	PMID:21266533
CPD	Human	dichlorine	multiple interactions	ISO	Cpd (Rattus norvegicus)	6480464	[Ozone co-treated with Chlorine] results in decreased expression of CPD mRNA	CTD	PMID:18636392
CPD	Human	dimethylarsinic acid	decreases expression	ISO	Cpd (Rattus norvegicus)	6480464	Cacodylic Acid results in decreased expression of CPD mRNA	CTD	PMID:17720352
CPD	Human	dorsomorphin	multiple interactions	EXP		6480464	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CPD mRNA	CTD	PMID:27188386
CPD	Human	doxorubicin	decreases expression	EXP		6480464	Doxorubicin results in decreased expression of CPD mRNA	CTD	PMID:29803840
CPD	Human	elemental selenium	decreases expression	EXP		6480464	Selenium results in decreased expression of CPD mRNA	CTD	PMID:19244175
CPD	Human	endosulfan	decreases expression	ISO	Cpd (Rattus norvegicus)	6480464	Endosulfan results in decreased expression of CPD mRNA	CTD	PMID:29391264
CPD	Human	epoxiconazole	decreases expression	ISO	Cpd (Mus musculus)	6480464	epoxiconazole results in decreased expression of CPD mRNA	CTD	PMID:35436446
CPD	Human	ethanol	increases expression	ISO	Cpd (Rattus norvegicus)	6480464	Ethanol results in increased expression of CPD mRNA	CTD	PMID:15353170
CPD	Human	ethanol	affects splicing	ISO	Cpd (Mus musculus)	6480464	Ethanol affects the splicing of CPD mRNA	CTD	PMID:30319688
CPD	Human	ethanol	multiple interactions	EXP		6480464	[[Gasoline co-treated with Ethanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of CPD mRNA	CTD	PMID:29432896
CPD	Human	folic acid	multiple interactions	ISO	Cpd (Mus musculus)	6480464	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of CPD gene	CTD	PMID:20938992
CPD	Human	folic acid	decreases expression	ISO	Cpd (Mus musculus)	6480464	Folic Acid results in decreased expression of CPD mRNA	CTD	PMID:25629700
CPD	Human	FR900359	affects phosphorylation	EXP		6480464	FR900359 affects the phosphorylation of CPD protein	CTD	PMID:37730182
CPD	Human	gamma-hexachlorocyclohexane	increases expression	ISO	Cpd (Rattus norvegicus)	6480464	Hexachlorocyclohexane results in increased expression of CPD mRNA	CTD	PMID:17785943
CPD	Human	gentamycin	increases expression	ISO	Cpd (Rattus norvegicus)	6480464	Gentamicins results in increased expression of CPD mRNA	CTD	PMID:22061828
CPD	Human	hydrogen cyanide	increases expression	ISO	Cpd (Mus musculus)	6480464	Hydrogen Cyanide results in increased expression of CPD mRNA	CTD	PMID:33914522
CPD	Human	isobutanol	multiple interactions	EXP		6480464	[[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of CPD mRNA	CTD	PMID:29432896
CPD	Human	isotretinoin	decreases expression	EXP		6480464	Isotretinoin results in decreased expression of CPD mRNA	CTD	PMID:20436886
CPD	Human	ivermectin	decreases expression	EXP		6480464	Ivermectin results in decreased expression of CPD protein	CTD	PMID:32959892
CPD	Human	L-methionine	multiple interactions	ISO	Cpd (Mus musculus)	6480464	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of CPD gene	CTD	PMID:20938992
CPD	Human	methapyrilene	decreases expression	ISO	Cpd (Rattus norvegicus)	6480464	Methapyrilene results in decreased expression of CPD mRNA	CTD	PMID:30467583
CPD	Human	methylmercury chloride	increases expression	EXP		6480464	methylmercuric chloride results in increased expression of CPD mRNA	CTD	PMID:23179753
CPD	Human	nitric oxide	affects chemical synthesis	EXP		6480464	CPD affects the chemical synthesis of Nitric Oxide	CTD	PMID:21688280
CPD	Human	nitric oxide	multiple interactions	EXP		6480464	[PRL results in increased expression of CPD mRNA] which results in increased chemical synthesis of Nitric Oxide and [Testosterone results in increased expression of CPD mRNA] which results in increased chemical synthesis of Nitric Oxide	CTD	PMID:21688280
CPD	Human	ozone	multiple interactions	ISO	Cpd (Rattus norvegicus)	6480464	[Ozone co-treated with Chlorine] results in decreased expression of CPD mRNA	CTD	PMID:18636392
CPD	Human	perfluorooctanoic acid	decreases expression	ISO	Cpd (Rattus norvegicus)	6480464	perfluorooctanoic acid results in decreased expression of CPD mRNA	CTD	PMID:19162173
CPD	Human	phenobarbital	decreases expression	ISO	Cpd (Mus musculus)	6480464	Phenobarbital results in decreased expression of CPD mRNA	CTD	PMID:23091169
CPD	Human	pirinixic acid	multiple interactions	EXP		6480464	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of CPD mRNA	CTD	PMID:19710929
CPD	Human	pirinixic acid	decreases expression	ISO	Cpd (Mus musculus)	6480464	pirinixic acid results in decreased expression of CPD mRNA	CTD	PMID:23811191
CPD	Human	potassium cyanide	increases expression	ISO	Cpd (Mus musculus)	6480464	Potassium Cyanide results in increased expression of CPD mRNA	CTD	PMID:33914522
CPD	Human	procymidone	increases expression	ISO	Cpd (Rattus norvegicus)	6480464	procymidone results in increased expression of CPD mRNA	CTD	PMID:15686871
CPD	Human	protein kinase inhibitor	multiple interactions	EXP		6480464	Protein Kinase Inhibitors inhibits the reaction [gardiquimod results in increased expression of CPD mRNA]	CTD	PMID:28003376
CPD	Human	rac-lactic acid	increases expression	EXP		6480464	Lactic Acid results in increased expression of CPD mRNA	CTD	PMID:30851411
CPD	Human	resveratrol	multiple interactions	EXP		6480464	[Plant Extracts co-treated with Resveratrol] results in increased expression of CPD mRNA	CTD	PMID:23557933
CPD	Human	rotenone	decreases expression	ISO	Cpd (Rattus norvegicus)	6480464	Rotenone results in decreased expression of CPD protein	CTD	PMID:35544339
CPD	Human	SB 431542	multiple interactions	EXP		6480464	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CPD mRNA	CTD	PMID:27188386
CPD	Human	selenium atom	decreases expression	EXP		6480464	Selenium results in decreased expression of CPD mRNA	CTD	PMID:19244175
CPD	Human	silicon dioxide	decreases expression	EXP		6480464	Silicon Dioxide analog results in decreased expression of CPD mRNA	CTD	PMID:25895662
CPD	Human	sodium arsenate	increases expression	ISO	Cpd (Mus musculus)	6480464	sodium arsenate results in increased expression of CPD mRNA	CTD	PMID:21795629
CPD	Human	sodium arsenite	increases expression	EXP		6480464	sodium arsenite results in increased expression of CPD mRNA	CTD	PMID:38568856
CPD	Human	sodium arsenite	multiple interactions	EXP		6480464	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of CPD mRNA	CTD	PMID:39836092
CPD	Human	succimer	multiple interactions	ISO	Cpd (Mus musculus)	6480464	[Succimer binds to Magnetite Nanoparticles] which results in increased expression of CPD mRNA and [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of CPD mRNA	CTD	PMID:21641980 and PMID:26378955
CPD	Human	sulforaphane	increases expression	EXP		6480464	sulforaphane results in increased expression of CPD mRNA	CTD	PMID:26833863
CPD	Human	testosterone	multiple interactions	EXP		6480464	[Testosterone results in increased expression of CPD mRNA] which results in increased chemical synthesis of Nitric Oxide and SRD5A1 promotes the reaction [Testosterone results in increased expression of CPD mRNA]	CTD	PMID:21688280
CPD	Human	testosterone	multiple interactions	ISO	Cpd (Rattus norvegicus)	6480464	[Estradiol co-treated with Testosterone] results in increased expression of CPD mRNA	CTD	PMID:11375906
CPD	Human	testosterone	increases expression	EXP		6480464	Testosterone results in increased expression of CPD mRNA and Testosterone results in increased expression of CPD protein	CTD	PMID:21688280
CPD	Human	tetrachloroethene	increases expression	ISO	Cpd (Mus musculus)	6480464	Tetrachloroethylene results in increased expression of CPD mRNA	CTD	PMID:28973375
CPD	Human	tetrachloromethane	affects expression	ISO	Cpd (Mus musculus)	6480464	Carbon Tetrachloride affects the expression of CPD mRNA	CTD	PMID:17484886
CPD	Human	thioacetamide	increases expression	ISO	Cpd (Rattus norvegicus)	6480464	Thioacetamide results in increased expression of CPD mRNA	CTD	PMID:34492290
CPD	Human	titanium dioxide	decreases methylation	ISO	Cpd (Mus musculus)	6480464	titanium dioxide results in decreased methylation of CPD gene	CTD	PMID:35295148
CPD	Human	trichloroethene	increases methylation	ISO	Cpd (Rattus norvegicus)	6480464	Trichloroethylene results in increased methylation of CPD gene	CTD	PMID:27618143
CPD	Human	trichostatin A	decreases expression	EXP		6480464	trichostatin A results in decreased expression of CPD mRNA	CTD	PMID:26272509
CPD	Human	trichostatin A	multiple interactions	EXP		6480464	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CPD mRNA	CTD	PMID:27188386
CPD	Human	triphenyl phosphate	affects expression	EXP		6480464	triphenyl phosphate affects the expression of CPD mRNA	CTD	PMID:37042841
CPD	Human	triptonide	increases expression	ISO	Cpd (Mus musculus)	6480464	triptonide results in increased expression of CPD mRNA	CTD	PMID:33045310
CPD	Human	troglitazone	decreases expression	ISO	Cpd (Mus musculus)	6480464	troglitazone results in decreased expression of CPD mRNA	CTD	PMID:28973697
CPD	Human	tungsten	decreases expression	ISO	Cpd (Mus musculus)	6480464	Tungsten results in decreased expression of CPD mRNA	CTD	PMID:30912803
CPD	Human	tunicamycin	decreases expression	ISO	Cpd (Mus musculus)	6480464	Tunicamycin results in decreased expression of CPD mRNA	CTD	PMID:17127020
CPD	Human	urethane	decreases expression	ISO	Cpd (Mus musculus)	6480464	Urethane results in decreased expression of CPD mRNA	CTD	PMID:16289808
CPD	Human	valproic acid	increases expression	EXP		6480464	Valproic Acid results in increased expression of CPD mRNA	CTD	PMID:23179753 and PMID:29154799
CPD	Human	valproic acid	affects splicing	ISO	Cpd (Rattus norvegicus)	6480464	Valproic Acid affects the splicing of CPD mRNA	CTD	PMID:29427782
CPD	Human	venlafaxine hydrochloride	increases expression	ISO	Cpd (Rattus norvegicus)	6480464	Venlafaxine Hydrochloride results in increased expression of CPD mRNA	CTD	PMID:25423262
CPD	Human	vinclozolin	decreases expression	ISO	Cpd (Rattus norvegicus)	6480464	vinclozolin results in decreased expression of CPD mRNA	CTD	PMID:23034163
CPD	Human	zoledronic acid	increases expression	EXP		6480464	zoledronic acid results in increased expression of CPD mRNA	CTD	PMID:20977926

Biological Process

Only show annotations with direct experimental evidence (0 objects hidden)

Object Symbol	Species	Term	Qualifier	Evidence	With	Reference	Notes	Source	Original Reference(s)
CPD	Human	cellular response to interleukin-2		ISO	Cpd (Rattus norvegicus)	9068941		RGD	PMID:11181555 and REF_RGD_ID:1298782
CPD	Human	peptide metabolic process	involved_in	IBA	PANTHER:PTN000163973 and Cpe (Rattus norvegicus)	150520179		GO_Central	GO_REF:0000033
CPD	Human	protein processing	involved_in	IBA	FB:FBgn0004648 more ...	150520179		GO_Central	GO_REF:0000033
CPD	Human	proteolysis	involved_in	IEA	UniProtKB-KW:KW-0645	150520179		UniProt	GO_REF:0000043
CPD	Human	proteolysis	involved_in	IEA	InterPro:IPR000834	150520179		InterPro	GO_REF:0000002

Cellular Component

Only show annotations with direct experimental evidence (0 objects hidden)

Object Symbol	Species	Term	Qualifier	Evidence	With	Reference	Notes	Source	Original Reference(s)
CPD	Human	extracellular exosome	located_in	HDA		150520179	PMID:19199708	UniProt	PMID:19199708
CPD	Human	extracellular space	is_active_in	IBA	MGI:1934569 more ...	150520179		GO_Central	GO_REF:0000033
CPD	Human	membrane	located_in	HDA		150520179	PMID:19946888	UniProt	PMID:19946888
CPD	Human	membrane	located_in	IEA	UniProtKB-KW:KW-0472	150520179		UniProt	GO_REF:0000043
CPD	Human	membrane	located_in	TAS		150520179	PMID:9064476	PINC	PMID:9064476
CPD	Human	nucleus	located_in	ISO	Cpd (Rattus norvegicus)	9068941	PMID:11181555	UniProt	PMID:11181555 and REF_RGD_ID:1298782
CPD	Human	perinuclear region of cytoplasm		ISO	Cpd (Rattus norvegicus)	9068941		RGD	PMID:15918796 and REF_RGD_ID:8693401
CPD	Human	plasma membrane	located_in	IEA	UniProtKB-SubCell:SL-0039	150520179		UniProt	GO_REF:0000044
CPD	Human	plasma membrane	located_in	IEA	UniProtKB-KW:KW-1003	150520179		UniProt	GO_REF:0000043
CPD	Human	trans-Golgi network		ISO	Cpd (Rattus norvegicus)	9068941		RGD	PMID:11181555 and REF_RGD_ID:1298782

Molecular Function

Only show annotations with direct experimental evidence (0 objects hidden)

Object Symbol	Species	Term	Qualifier	Evidence	With	Reference	Notes	Source	Original Reference(s)
CPD	Human	carboxypeptidase activity	enables	IEA	UniProtKB-KW:KW-0121	150520179		UniProt	GO_REF:0000043
CPD	Human	hydrolase activity	enables	IEA	UniProtKB-KW:KW-0378	150520179		UniProt	GO_REF:0000043
CPD	Human	metal ion binding	enables	IEA	UniProtKB-KW:KW-0479	150520179		UniProt	GO_REF:0000043
CPD	Human	metallocarboxypeptidase activity	enables	IEA	EC:3.4.17.22	150520179		UniProt	GO_REF:0000003
CPD	Human	metallocarboxypeptidase activity	enables	IBA	FB:FBgn0004648 more ...	150520179		GO_Central	GO_REF:0000033
CPD	Human	metallocarboxypeptidase activity	enables	IEA	InterPro:IPR000834	150520179		InterPro	GO_REF:0000002
CPD	Human	metallopeptidase activity	enables	IEA	UniProtKB-KW:KW-0482	150520179		UniProt	GO_REF:0000043
CPD	Human	peptidase activity	enables	IEA	UniProtKB-KW:KW-0645	150520179		UniProt	GO_REF:0000043
CPD	Human	protein phosphatase 2A binding		ISO	Ppp2ca (Rattus norvegicus)	9068941		RGD	PMID:15918796 and REF_RGD_ID:8693401
CPD	Human	protein-containing complex binding		ISO	Ppp2ca (Rattus norvegicus) and Igbp1 (Rattus norvegicus)	9068941		RGD	PMID:15918796 and REF_RGD_ID:8693401
CPD	Human	serine-type carboxypeptidase activity	enables	TAS		150520179	PMID:9064476	PINC	PMID:9064476
CPD	Human	zinc ion binding	enables	IEA	InterPro:IPR000834	150520179		InterPro	GO_REF:0000002

#	Reference Title	Reference Citation
1.	GOAs Human GO annotations	GOA_HUMAN data from the GO Consortium
2.	ClinVar Automated Import and Annotation Pipeline	RGD automated import pipeline for ClinVar variants, variant-to-disease annotations and gene-to-disease annotations
3.	Data Import for Chemical-Gene Interactions	RGD automated import pipeline for gene-chemical interactions

PMID:8619474	PMID:9064476	PMID:9355738	PMID:9490632	PMID:9628828	PMID:9714835	PMID:9815277	PMID:10829017	PMID:11306718	PMID:12417617	PMID:12477932	PMID:12643288
PMID:12754519	PMID:15489334	PMID:15918796	PMID:17255364	PMID:17641957	PMID:18535109	PMID:19199708	PMID:19322201	PMID:19946888	PMID:20682791	PMID:21628999	PMID:21873635
PMID:21988832	PMID:22268729	PMID:22354994	PMID:22902628	PMID:23246001	PMID:23589395	PMID:24337577	PMID:24433040	PMID:24615730	PMID:24639526	PMID:25294878	PMID:25437307
PMID:25921289	PMID:26186194	PMID:26638075	PMID:27375898	PMID:27494742	PMID:27880917	PMID:28364216	PMID:28380382	PMID:28514442	PMID:28611215	PMID:28675297	PMID:28718761
PMID:28986522	PMID:29180619	PMID:29395067	PMID:29507755	PMID:29568061	PMID:30194290	PMID:30639242	PMID:31056421	PMID:31073040	PMID:31586073	PMID:31617661	PMID:31678930
PMID:31732153	PMID:31741433	PMID:31871319	PMID:31932471	PMID:32707033	PMID:32838362	PMID:32877691	PMID:32963011	PMID:33545068	PMID:33726789	PMID:33845483	PMID:33957083
PMID:33961781	PMID:34079125	PMID:34369648	PMID:34373451	PMID:34432599	PMID:34597346	PMID:34702444	PMID:34709727	PMID:34857952	PMID:34882091	PMID:35241646	PMID:35271311
PMID:35384245	PMID:35696571	PMID:35944360	PMID:36180527	PMID:36215168	PMID:36237976	PMID:36610398	PMID:36976175	PMID:37768083	PMID:37788672	PMID:38270169	PMID:38569033
PMID:39231216	PMID:39499777

CPD
(Homo sapiens - human)

Human Assembly	Chr	Position (strand)	Source	Genome Browsers
Human Assembly	Chr	Position (strand)	Source	JBrowse	NCBI	UCSC	Ensembl
GRCh38	17	30,378,927 - 30,469,989 (+)	NCBI	GRCh38	GRCh38	hg38	GRCh38
GRCh38.p14 Ensembl	17	30,378,927 - 30,469,989 (+)	Ensembl	GRCh38		hg38	GRCh38
GRCh37	17	28,705,945 - 28,797,007 (+)	NCBI	GRCh37	GRCh37	hg19	GRCh37
Build 36	17	25,730,110 - 25,819,825 (+)	NCBI	NCBI36	Build 36	hg18	NCBI36
Build 34	17	25,730,109 - 25,819,825	NCBI
Celera	17	25,567,489 - 25,657,199 (+)	NCBI		Celera
Cytogenetic Map	17	q11.2	NCBI
HuRef	17	24,915,981 - 25,006,704 (+)	NCBI		HuRef
CHM1_1	17	28,768,174 - 28,859,153 (+)	NCBI		CHM1_1
T2T-CHM13v2.0	17	31,323,558 - 31,414,615 (+)	NCBI		T2T-CHM13v2.0

Cpd
(Mus musculus - house mouse)

Mouse Assembly	Chr	Position (strand)	Source	Genome Browsers
Mouse Assembly	Chr	Position (strand)	Source	JBrowse	NCBI	UCSC	Ensembl
GRCm39	11	76,668,034 - 76,737,834 (-)	NCBI	GRCm39	GRCm39	mm39
GRCm39 Ensembl	11	76,669,250 - 76,737,844 (-)	Ensembl		GRCm39 Ensembl
GRCm38	11	76,777,208 - 76,847,008 (-)	NCBI	GRCm38	GRCm38	mm10	GRCm38
GRCm38.p6 Ensembl	11	76,778,424 - 76,847,018 (-)	Ensembl	GRCm38		mm10	GRCm38
MGSCv37	11	76,590,710 - 76,660,510 (-)	NCBI	GRCm37	MGSCv37	mm9	NCBIm37
MGSCv36	11	76,598,184 - 76,663,191 (-)	NCBI		MGSCv36	mm8
Celera	11	84,282,160 - 84,345,782 (-)	NCBI		Celera
Cytogenetic Map	11	B5	NCBI
cM Map	11	46.05	NCBI

Cpd
(Rattus norvegicus - Norway rat)

Rat Assembly	Chr	Position (strand)	Source	Genome Browsers
Rat Assembly	Chr	Position (strand)	Source	JBrowse	NCBI	UCSC	Ensembl
GRCr8	10	62,121,681 - 62,185,638 (-)	NCBI		GRCr8
mRatBN7.2	10	61,623,528 - 61,687,491 (-)	NCBI	mRatBN7.2	mRatBN7.2
mRatBN7.2 Ensembl	10	61,623,526 - 61,687,491 (-)	Ensembl		mRatBN7.2 Ensembl
UTH_Rnor_SHR_Utx	10	66,269,189 - 66,333,145 (-)	NCBI	Rnor_SHR	UTH_Rnor_SHR_Utx
UTH_Rnor_SHRSP_BbbUtx_1.0	10	65,774,660 - 65,838,616 (-)	NCBI	Rnor_SHRSP	UTH_Rnor_SHRSP_BbbUtx_1.0
UTH_Rnor_WKY_Bbb_1.0	10	61,244,000 - 61,309,462 (-)	NCBI	Rnor_WKY	UTH_Rnor_WKY_Bbb_1.0
Rnor_6.0	10	63,325,764 - 63,389,811 (+)	NCBI	Rnor6.0	Rnor_6.0	rn6	Rnor6.0
Rnor_6.0 Ensembl	10	63,325,199 - 63,389,817 (+)	Ensembl	Rnor6.0		rn6	Rnor6.0
Rnor_5.0	10	63,024,264 - 63,088,486 (+)	NCBI	Rnor5.0	Rnor_5.0	rn5	Rnor5.0
RGSC_v3.4	10	67,327,272 - 67,390,836 (+)	NCBI	RGSC3.4	RGSC_v3.4	rn4	RGSC3.4
RGSC_v3.1	10	67,340,894 - 67,404,459 (+)	NCBI
Celera	10	60,635,370 - 60,698,539 (-)	NCBI		Celera
Cytogenetic Map	10	q24	NCBI

Cpd
(Chinchilla lanigera - long-tailed chinchilla)

Chinchilla Assembly	Chr	Position (strand)	Source	Genome Browsers
Chinchilla Assembly	Chr	Position (strand)	Source	JBrowse	NCBI	UCSC	Ensembl
ChiLan1.0 Ensembl	NW_004955481	2,889,156 - 2,951,495 (-)	Ensembl	ChiLan1.0
ChiLan1.0	NW_004955481	2,885,243 - 2,951,574 (-)	NCBI	ChiLan1.0	ChiLan1.0

CPD
(Pan paniscus - bonobo/pygmy chimpanzee)

Bonobo Assembly	Chr	Position (strand)	Source	Genome Browsers
Bonobo Assembly	Chr	Position (strand)	Source	JBrowse	NCBI	UCSC	Ensembl
NHGRI_mPanPan1-v2	19	33,983,409 - 34,070,840 (-)	NCBI		NHGRI_mPanPan1-v2
NHGRI_mPanPan1	17	35,864,051 - 35,951,350 (-)	NCBI		NHGRI_mPanPan1
Mhudiblu_PPA_v0	17	26,302,112 - 26,389,049 (-)	NCBI	Mhudiblu_PPA_v0	Mhudiblu_PPA_v0	panPan3
PanPan1.1	17	26,821,641 - 26,908,252 (-)	NCBI	panpan1.1	PanPan1.1	panPan2
PanPan1.1 Ensembl	17	26,821,641 - 26,908,257 (-)	Ensembl	panpan1.1		panPan2

CPD
(Canis lupus familiaris - dog)

Dog Assembly	Chr	Position (strand)	Source	Genome Browsers
Dog Assembly	Chr	Position (strand)	Source	JBrowse	NCBI	UCSC	Ensembl
CanFam3.1	9	44,388,147 - 44,469,775 (+)	NCBI	CanFam3.1	CanFam3.1	canFam3	CanFam3.1
CanFam3.1 Ensembl	9	44,388,219 - 44,466,074 (+)	Ensembl	CanFam3.1		canFam3	CanFam3.1
Dog10K_Boxer_Tasha	9	43,539,778 - 43,621,450 (+)	NCBI		Dog10K_Boxer_Tasha
ROS_Cfam_1.0	9	45,207,559 - 45,287,811 (+)	NCBI		ROS_Cfam_1.0
ROS_Cfam_1.0 Ensembl	9	45,207,487 - 45,286,195 (+)	Ensembl		ROS_Cfam_1.0 Ensembl
UMICH_Zoey_3.1	9	43,987,222 - 44,067,108 (+)	NCBI		UMICH_Zoey_3.1
UNSW_CanFamBas_1.0	9	44,274,017 - 44,354,213 (+)	NCBI		UNSW_CanFamBas_1.0
UU_Cfam_GSD_1.0	9	44,358,343 - 44,440,254 (+)	NCBI		UU_Cfam_GSD_1.0

Cpd
(Ictidomys tridecemlineatus - thirteen-lined ground squirrel)

Squirrel Assembly	Chr	Position (strand)	Source	Genome Browsers
Squirrel Assembly	Chr	Position (strand)	Source	JBrowse	NCBI	UCSC	Ensembl
HiC_Itri_2	NW_024405602	43,502,080 - 43,576,174 (+)	NCBI		HiC_Itri_2
SpeTri2.0 Ensembl	NW_004936538	6,379,999 - 6,454,122 (+)	Ensembl	SpeTri2.0	SpeTri2.0 Ensembl
SpeTri2.0	NW_004936538	6,380,046 - 6,454,117 (+)	NCBI	SpeTri2.0	SpeTri2.0		SpeTri2.0

CPD
(Sus scrofa - pig)

Pig Assembly	Chr	Position (strand)	Source	Genome Browsers
Pig Assembly	Chr	Position (strand)	Source	JBrowse	NCBI	UCSC	Ensembl
Sscrofa11.1 Ensembl	12	46,462,265 - 46,533,022 (+)	Ensembl	Sscrofa11.1		susScr11	Sscrofa11.1
Sscrofa11.1	12	46,462,203 - 46,533,032 (+)	NCBI	Sscrofa11.1	Sscrofa11.1	susScr11	Sscrofa11.1
Sscrofa10.2	12	48,551,808 - 48,622,822 (+)	NCBI	Sscrofa10.2	Sscrofa10.2	susScr3

CPD
(Chlorocebus sabaeus - green monkey)

Green Monkey Assembly	Chr	Position (strand)	Source	Genome Browsers
Green Monkey Assembly	Chr	Position (strand)	Source	JBrowse	NCBI	UCSC	Ensembl
ChlSab1.1	16	24,106,406 - 24,196,998 (+)	NCBI	ChlSab1.1	ChlSab1.1	chlSab2
ChlSab1.1 Ensembl	16	24,106,883 - 24,193,129 (+)	Ensembl	ChlSab1.1	ChlSab1.1 Ensembl	chlSab2
Vero_WHO_p1.0	NW_023666075	5,862,697 - 5,952,891 (-)	NCBI	Vero_WHO_p1.0	Vero_WHO_p1.0

Cpd
(Heterocephalus glaber - naked mole-rat)

Naked Mole-Rat Assembly	Chr	Position (strand)	Source	Genome Browsers
Naked Mole-Rat Assembly	Chr	Position (strand)	Source	JBrowse	NCBI	UCSC	Ensembl
HetGla_female_1.0 Ensembl	NW_004624786	2,866,059 - 2,941,879 (+)	Ensembl	HetGla_female_1.0	HetGla_female_1.0 Ensembl	hetGla2
HetGla 1.0	NW_004624786	2,866,020 - 2,940,615 (+)	NCBI	HetGla_female_1.0	HetGla 1.0	hetGla2

Variants in CPD
99 total Variants

Name	Type	Condition(s)	Position(s)	Clinical significance
NM_001199775.1(CPD):c.634C>T (p.Leu212Phe)	single nucleotide variant	Malignant melanoma [RCV000063182]	Chr17:30422741 [GRCh38] Chr17:28749759 [GRCh37] Chr17:25773885 [NCBI36] Chr17:17q11.2	not provided
GRCh38/hg38 17q11.2(chr17:28947825-32490020)x1	copy number loss	See cases [RCV000143027]	Chr17:28947825..32490020 [GRCh38] Chr17:27274843..30817038 [GRCh37] Chr17:24298969..27841151 [NCBI36] Chr17:17q11.2	pathogenic
GRCh37/hg19 17q11.1-11.2(chr17:25403446-31685464)x3	copy number gain	not provided [RCV000762776]	Chr17:25403446..31685464 [GRCh37] Chr17:17q11.1-11.2	likely pathogenic
GRCh37/hg19 17p13.3-q25.3(chr17:526-81041938)	copy number gain	See cases [RCV000511439]	Chr17:526..81041938 [GRCh37] Chr17:17p13.3-q25.3	pathogenic
NM_001304.5(CPD):c.2420G>T (p.Arg807Met)	single nucleotide variant	not specified [RCV004284019]	Chr17:30443848 [GRCh38] Chr17:28770866 [GRCh37] Chr17:17q11.2	uncertain significance
NM_001304.5(CPD):c.2013T>A (p.His671Gln)	single nucleotide variant	not specified [RCV004322867]	Chr17:30427554 [GRCh38] Chr17:28754572 [GRCh37] Chr17:17q11.2	uncertain significance
NM_001304.5(CPD):c.26C>A (p.Pro9Gln)	single nucleotide variant	not specified [RCV004303781]	Chr17:30379006 [GRCh38] Chr17:28706024 [GRCh37] Chr17:17q11.2	uncertain significance
NM_001304.5(CPD):c.2762G>A (p.Arg921His)	single nucleotide variant	not specified [RCV004330697]	Chr17:30445909 [GRCh38] Chr17:28772927 [GRCh37] Chr17:17q11.2	uncertain significance
NM_001304.5(CPD):c.2342A>G (p.Asn781Ser)	single nucleotide variant	not specified [RCV004302976]	Chr17:30442419 [GRCh38] Chr17:28769437 [GRCh37] Chr17:17q11.2	uncertain significance
GRCh37/hg19 17p13.3-q25.3(chr17:526-81041938)x3	copy number gain	See cases [RCV000512441]	Chr17:526..81041938 [GRCh37] Chr17:17p13.3-q25.3	pathogenic
GRCh37/hg19 17q11.1-11.2(chr17:25248166-30645676)x1	copy number loss	Mitogen-activated protein kinase kinase inhibitor response [RCV000626439]	Chr17:25248166..30645676 [GRCh37] Chr17:17q11.1-11.2	drug response
GRCh37/hg19 17p13.3-q25.3(chr17:8547-81060040)x3	copy number gain	not provided [RCV000739324]	Chr17:8547..81060040 [GRCh37] Chr17:17p13.3-q25.3	pathogenic
GRCh37/hg19 17p13.3-q25.3(chr17:7214-81058310)x3	copy number gain	not provided [RCV000739320]	Chr17:7214..81058310 [GRCh37] Chr17:17p13.3-q25.3	pathogenic
GRCh37/hg19 17p13.3-q25.3(chr17:12344-81057996)x3	copy number gain	not provided [RCV000739325]	Chr17:12344..81057996 [GRCh37] Chr17:17p13.3-q25.3	pathogenic
NM_001304.5(CPD):c.13C>A (p.Arg5=)	single nucleotide variant	not provided [RCV000959380]	Chr17:30378993 [GRCh38] Chr17:28706011 [GRCh37] Chr17:17q11.2	benign
NM_001304.5(CPD):c.1496A>G (p.Lys499Arg)	single nucleotide variant	not provided [RCV000949598]	Chr17:30422862 [GRCh38] Chr17:28749880 [GRCh37] Chr17:17q11.2	benign
GRCh37/hg19 17p11.2-q21.2(chr17:21690653-38772647)x3	copy number gain	not provided [RCV000846852]	Chr17:21690653..38772647 [GRCh37] Chr17:17p11.2-q21.2	pathogenic
NM_001304.5(CPD):c.1150G>A (p.Val384Met)	single nucleotide variant	not specified [RCV004319773]	Chr17:30421676 [GRCh38] Chr17:28748694 [GRCh37] Chr17:17q11.2	uncertain significance
NM_001304.5(CPD):c.2031T>G (p.Val677=)	single nucleotide variant	not provided [RCV000974133]	Chr17:30431785 [GRCh38] Chr17:28758803 [GRCh37] Chr17:17q11.2	benign
NM_001304.5(CPD):c.2696C>T (p.Thr899Ile)	single nucleotide variant	not provided [RCV000915269]	Chr17:30445843 [GRCh38] Chr17:28772861 [GRCh37] Chr17:17q11.2	benign
NM_001304.5(CPD):c.3051G>C (p.Lys1017Asn)	single nucleotide variant	not specified [RCV004610981]	Chr17:30449730 [GRCh38] Chr17:28776748 [GRCh37] Chr17:17q11.2	uncertain significance
NC_000017.10:g.(?_27573882)_(29576157_?)del	deletion	Neurofibromatosis, type 1 [RCV003109263]	Chr17:27573882..29576157 [GRCh37] Chr17:17q11.2	pathogenic
NC_000017.10:g.(?_26684694)_(29701173_?)dup	duplication	not provided [RCV003123018]	Chr17:26684694..29701173 [GRCh37] Chr17:17q11.2	uncertain significance
NM_001304.5(CPD):c.470C>T (p.Ala157Val)	single nucleotide variant	not specified [RCV004312877]	Chr17:30379450 [GRCh38] Chr17:28706468 [GRCh37] Chr17:17q11.2	uncertain significance
NM_001304.5(CPD):c.3575G>T (p.Arg1192Leu)	single nucleotide variant	not specified [RCV004312709]	Chr17:30461256 [GRCh38] Chr17:28788274 [GRCh37] Chr17:17q11.2	uncertain significance
NM_001304.5(CPD):c.685C>G (p.Pro229Ala)	single nucleotide variant	not specified [RCV004314782]	Chr17:30379665 [GRCh38] Chr17:28706683 [GRCh37] Chr17:17q11.2	uncertain significance
NM_001304.5(CPD):c.88C>T (p.Arg30Trp)	single nucleotide variant	not specified [RCV004296760]	Chr17:30379068 [GRCh38] Chr17:28706086 [GRCh37] Chr17:17q11.2	uncertain significance
NM_001304.5(CPD):c.460C>T (p.Arg154Cys)	single nucleotide variant	not specified [RCV004238224]	Chr17:30379440 [GRCh38] Chr17:28706458 [GRCh37] Chr17:17q11.2	uncertain significance
NM_001304.5(CPD):c.3469G>C (p.Glu1157Gln)	single nucleotide variant	not specified [RCV004085435]	Chr17:30456497 [GRCh38] Chr17:28783515 [GRCh37] Chr17:17q11.2	uncertain significance
NM_001304.5(CPD):c.2761C>T (p.Arg921Cys)	single nucleotide variant	not specified [RCV004115502]	Chr17:30445908 [GRCh38] Chr17:28772926 [GRCh37] Chr17:17q11.2	uncertain significance
NM_001304.5(CPD):c.4063T>C (p.Ser1355Pro)	single nucleotide variant	not specified [RCV004133137]	Chr17:30464734 [GRCh38] Chr17:28791752 [GRCh37] Chr17:17q11.2	uncertain significance
NM_001304.5(CPD):c.1678A>C (p.Ile560Leu)	single nucleotide variant	not specified [RCV004116073]	Chr17:30423526 [GRCh38] Chr17:28750544 [GRCh37] Chr17:17q11.2	uncertain significance
NM_001304.5(CPD):c.2741G>C (p.Gly914Ala)	single nucleotide variant	not specified [RCV004136052]	Chr17:30445888 [GRCh38] Chr17:28772906 [GRCh37] Chr17:17q11.2	uncertain significance
NM_001304.5(CPD):c.951C>G (p.Phe317Leu)	single nucleotide variant	not specified [RCV004228010]	Chr17:30385193 [GRCh38] Chr17:28712211 [GRCh37] Chr17:17q11.2	uncertain significance
NM_001304.5(CPD):c.3874C>T (p.Arg1292Trp)	single nucleotide variant	not specified [RCV004160584]	Chr17:30462427 [GRCh38] Chr17:28789445 [GRCh37] Chr17:17q11.2	uncertain significance
NM_001304.5(CPD):c.685C>T (p.Pro229Ser)	single nucleotide variant	not specified [RCV004078356]	Chr17:30379665 [GRCh38] Chr17:28706683 [GRCh37] Chr17:17q11.2	uncertain significance
NM_001304.5(CPD):c.355C>G (p.Pro119Ala)	single nucleotide variant	not specified [RCV004157670]	Chr17:30379335 [GRCh38] Chr17:28706353 [GRCh37] Chr17:17q11.2	uncertain significance
NM_001304.5(CPD):c.2192A>G (p.His731Arg)	single nucleotide variant	not specified [RCV004227432]	Chr17:30439039 [GRCh38] Chr17:28766057 [GRCh37] Chr17:17q11.2	uncertain significance
NM_001304.5(CPD):c.370C>T (p.Pro124Ser)	single nucleotide variant	not specified [RCV004117463]	Chr17:30379350 [GRCh38] Chr17:28706368 [GRCh37] Chr17:17q11.2	uncertain significance
NM_001304.5(CPD):c.3875G>A (p.Arg1292Gln)	single nucleotide variant	not specified [RCV004184602]	Chr17:30462428 [GRCh38] Chr17:28789446 [GRCh37] Chr17:17q11.2	uncertain significance
NM_001304.5(CPD):c.3703A>G (p.Asn1235Asp)	single nucleotide variant	not specified [RCV004118786]	Chr17:30461949 [GRCh38] Chr17:28788967 [GRCh37] Chr17:17q11.2	uncertain significance
NM_001304.5(CPD):c.233G>T (p.Gly78Val)	single nucleotide variant	not specified [RCV004137917]	Chr17:30379213 [GRCh38] Chr17:28706231 [GRCh37] Chr17:17q11.2	uncertain significance
NM_001304.5(CPD):c.4007G>A (p.Arg1336Gln)	single nucleotide variant	not specified [RCV004110099]	Chr17:30464678 [GRCh38] Chr17:28791696 [GRCh37] Chr17:17q11.2	uncertain significance
NM_001304.5(CPD):c.2290G>T (p.Gly764Cys)	single nucleotide variant	not specified [RCV004129435]	Chr17:30442367 [GRCh38] Chr17:28769385 [GRCh37] Chr17:17q11.2	uncertain significance
NM_001304.5(CPD):c.3985A>G (p.Arg1329Gly)	single nucleotide variant	not specified [RCV004167385]	Chr17:30464656 [GRCh38] Chr17:28791674 [GRCh37] Chr17:17q11.2	uncertain significance
NM_001304.5(CPD):c.497G>T (p.Arg166Leu)	single nucleotide variant	not specified [RCV004146589]	Chr17:30379477 [GRCh38] Chr17:28706495 [GRCh37] Chr17:17q11.2	uncertain significance
NM_001304.5(CPD):c.227T>G (p.Leu76Arg)	single nucleotide variant	not specified [RCV004241553]	Chr17:30379207 [GRCh38] Chr17:28706225 [GRCh37] Chr17:17q11.2	uncertain significance
NM_001304.5(CPD):c.1943C>T (p.Thr648Met)	single nucleotide variant	not specified [RCV004231524]	Chr17:30427484 [GRCh38] Chr17:28754502 [GRCh37] Chr17:17q11.2	uncertain significance
NM_001304.5(CPD):c.137C>T (p.Ala46Val)	single nucleotide variant	not specified [RCV004150380]	Chr17:30379117 [GRCh38] Chr17:28706135 [GRCh37] Chr17:17q11.2	uncertain significance
NM_001304.5(CPD):c.1924G>T (p.Val642Phe)	single nucleotide variant	not specified [RCV004146485]	Chr17:30427465 [GRCh38] Chr17:28754483 [GRCh37] Chr17:17q11.2	uncertain significance
NM_001304.5(CPD):c.3239T>C (p.Ile1080Thr)	single nucleotide variant	not specified [RCV004106462]	Chr17:30455372 [GRCh38] Chr17:28782390 [GRCh37] Chr17:17q11.2	uncertain significance
NM_001304.5(CPD):c.4096G>A (p.Asp1366Asn)	single nucleotide variant	not specified [RCV004126927]	Chr17:30464767 [GRCh38] Chr17:28791785 [GRCh37] Chr17:17q11.2	uncertain significance
NM_001304.5(CPD):c.2126A>G (p.Lys709Arg)	single nucleotide variant	not specified [RCV004156823]	Chr17:30431880 [GRCh38] Chr17:28758898 [GRCh37] Chr17:17q11.2	uncertain significance
NM_001304.5(CPD):c.1277G>A (p.Gly426Glu)	single nucleotide variant	not specified [RCV004108548]	Chr17:30421803 [GRCh38] Chr17:28748821 [GRCh37] Chr17:17q11.2	uncertain significance
NM_001304.5(CPD):c.2693C>T (p.Thr898Ile)	single nucleotide variant	not specified [RCV004203289]	Chr17:30445840 [GRCh38] Chr17:28772858 [GRCh37] Chr17:17q11.2	uncertain significance
NM_001304.5(CPD):c.3479G>A (p.Ser1160Asn)	single nucleotide variant	not specified [RCV004152640]	Chr17:30456507 [GRCh38] Chr17:28783525 [GRCh37] Chr17:17q11.2	uncertain significance
NM_001304.5(CPD):c.170G>C (p.Arg57Pro)	single nucleotide variant	not specified [RCV004148072]	Chr17:30379150 [GRCh38] Chr17:28706168 [GRCh37] Chr17:17q11.2	uncertain significance
NM_001304.5(CPD):c.3973A>G (p.Ile1325Val)	single nucleotide variant	not specified [RCV004116074]	Chr17:30464644 [GRCh38] Chr17:28791662 [GRCh37] Chr17:17q11.2	uncertain significance
NM_001304.5(CPD):c.1424C>T (p.Ser475Leu)	single nucleotide variant	not specified [RCV004208133]	Chr17:30422790 [GRCh38] Chr17:28749808 [GRCh37] Chr17:17q11.2	uncertain significance
NM_001304.5(CPD):c.2971G>T (p.Ala991Ser)	single nucleotide variant	not specified [RCV004208811]	Chr17:30449650 [GRCh38] Chr17:28776668 [GRCh37] Chr17:17q11.2	uncertain significance
NM_001304.5(CPD):c.1172C>T (p.Ser391Phe)	single nucleotide variant	not specified [RCV004086470]	Chr17:30421698 [GRCh38] Chr17:28748716 [GRCh37] Chr17:17q11.2	uncertain significance
NM_001304.5(CPD):c.2933A>G (p.Asn978Ser)	single nucleotide variant	not specified [RCV004330762]	Chr17:30449612 [GRCh38] Chr17:28776630 [GRCh37] Chr17:17q11.2	uncertain significance
NM_001304.5(CPD):c.18C>G (p.Asp6Glu)	single nucleotide variant	not specified [RCV004250356]	Chr17:30378998 [GRCh38] Chr17:28706016 [GRCh37] Chr17:17q11.2	likely benign
NM_001304.5(CPD):c.515A>G (p.Asn172Ser)	single nucleotide variant	not specified [RCV004267488]	Chr17:30379495 [GRCh38] Chr17:28706513 [GRCh37] Chr17:17q11.2	uncertain significance
NM_001304.5(CPD):c.515A>C (p.Asn172Thr)	single nucleotide variant	not specified [RCV004275737]	Chr17:30379495 [GRCh38] Chr17:28706513 [GRCh37] Chr17:17q11.2	uncertain significance
NM_001304.5(CPD):c.618C>G (p.Ser206Arg)	single nucleotide variant	not specified [RCV004260189]	Chr17:30379598 [GRCh38] Chr17:28706616 [GRCh37] Chr17:17q11.2	uncertain significance
NM_001304.5(CPD):c.1486A>G (p.Ile496Val)	single nucleotide variant	not specified [RCV004252937]	Chr17:30422852 [GRCh38] Chr17:28749870 [GRCh37] Chr17:17q11.2	uncertain significance
NM_001304.5(CPD):c.2636A>G (p.Asn879Ser)	single nucleotide variant	not specified [RCV004266516]	Chr17:30445783 [GRCh38] Chr17:28772801 [GRCh37] Chr17:17q11.2	likely benign
NM_001304.5(CPD):c.2615G>A (p.Arg872Gln)	single nucleotide variant	not specified [RCV004280581]	Chr17:30445762 [GRCh38] Chr17:28772780 [GRCh37] Chr17:17q11.2	uncertain significance
NM_001304.5(CPD):c.2215T>C (p.Trp739Arg)	single nucleotide variant	not specified [RCV004276574]	Chr17:30439062 [GRCh38] Chr17:28766080 [GRCh37] Chr17:17q11.2	uncertain significance
NM_001304.5(CPD):c.685C>A (p.Pro229Thr)	single nucleotide variant	not specified [RCV004339183]	Chr17:30379665 [GRCh38] Chr17:28706683 [GRCh37] Chr17:17q11.2	uncertain significance
NM_001304.5(CPD):c.1225C>T (p.His409Tyr)	single nucleotide variant	not specified [RCV004365525]	Chr17:30421751 [GRCh38] Chr17:28748769 [GRCh37] Chr17:17q11.2	uncertain significance
GRCh37/hg19 17q11.2(chr17:28387597-30812008)x1	copy number loss	not provided [RCV003483317]	Chr17:28387597..30812008 [GRCh37] Chr17:17q11.2	pathogenic
NM_001304.5(CPD):c.1380G>A (p.Arg460=)	single nucleotide variant	not provided [RCV003413192]	Chr17:30422746 [GRCh38] Chr17:28749764 [GRCh37] Chr17:17q11.2	likely benign
GRCh37/hg19 17q11.2(chr17:28277040-30903559)x1	copy number loss	not specified [RCV003987216]	Chr17:28277040..30903559 [GRCh37] Chr17:17q11.2	pathogenic
NM_001304.5(CPD):c.1229A>G (p.Asn410Ser)	single nucleotide variant	not specified [RCV004372398]	Chr17:30421755 [GRCh38] Chr17:28748773 [GRCh37] Chr17:17q11.2	uncertain significance
NM_001304.5(CPD):c.1553A>G (p.Asn518Ser)	single nucleotide variant	not specified [RCV004372401]	Chr17:30422919 [GRCh38] Chr17:28749937 [GRCh37] Chr17:17q11.2	uncertain significance
NM_001304.5(CPD):c.2624C>T (p.Thr875Ile)	single nucleotide variant	not specified [RCV004372402]	Chr17:30445771 [GRCh38] Chr17:28772789 [GRCh37] Chr17:17q11.2	uncertain significance
NM_001304.5(CPD):c.2950G>A (p.Glu984Lys)	single nucleotide variant	not specified [RCV004372403]	Chr17:30449629 [GRCh38] Chr17:28776647 [GRCh37] Chr17:17q11.2	uncertain significance
NM_001304.5(CPD):c.3283T>A (p.Leu1095Ile)	single nucleotide variant	not specified [RCV004372406]	Chr17:30455416 [GRCh38] Chr17:28782434 [GRCh37] Chr17:17q11.2	uncertain significance
NM_001304.5(CPD):c.3992A>G (p.Lys1331Arg)	single nucleotide variant	not specified [RCV004372409]	Chr17:30464663 [GRCh38] Chr17:28791681 [GRCh37] Chr17:17q11.2	uncertain significance
NM_001304.5(CPD):c.623G>C (p.Arg208Pro)	single nucleotide variant	not specified [RCV004374388]	Chr17:30379603 [GRCh38] Chr17:28706621 [GRCh37] Chr17:17q11.2	uncertain significance
NM_001304.5(CPD):c.3664A>G (p.Lys1222Glu)	single nucleotide variant	not specified [RCV004372408]	Chr17:30461910 [GRCh38] Chr17:28788928 [GRCh37] Chr17:17q11.2	uncertain significance
NM_001304.5(CPD):c.899C>G (p.Pro300Arg)	single nucleotide variant	not specified [RCV004374389]	Chr17:30385141 [GRCh38] Chr17:28712159 [GRCh37] Chr17:17q11.2	uncertain significance
NM_001304.5(CPD):c.412A>G (p.Met138Val)	single nucleotide variant	not specified [RCV004372411]	Chr17:30379392 [GRCh38] Chr17:28706410 [GRCh37] Chr17:17q11.2	uncertain significance
NM_001304.5(CPD):c.2962C>T (p.Arg988Cys)	single nucleotide variant	not specified [RCV004372404]	Chr17:30449641 [GRCh38] Chr17:28776659 [GRCh37] Chr17:17q11.2	uncertain significance
NM_001304.5(CPD):c.901A>G (p.Ile301Val)	single nucleotide variant	not specified [RCV004374390]	Chr17:30385143 [GRCh38] Chr17:28712161 [GRCh37] Chr17:17q11.2	uncertain significance
NM_001304.5(CPD):c.1247T>G (p.Phe416Cys)	single nucleotide variant	not specified [RCV004372399]	Chr17:30421773 [GRCh38] Chr17:28748791 [GRCh37] Chr17:17q11.2	uncertain significance
NM_001304.5(CPD):c.1477T>C (p.Tyr493His)	single nucleotide variant	not specified [RCV004372400]	Chr17:30422843 [GRCh38] Chr17:28749861 [GRCh37] Chr17:17q11.2	likely benign
NM_001304.5(CPD):c.3055C>T (p.Pro1019Ser)	single nucleotide variant	not specified [RCV004372405]	Chr17:30449734 [GRCh38] Chr17:28776752 [GRCh37] Chr17:17q11.2	uncertain significance
NM_001304.5(CPD):c.4019A>G (p.His1340Arg)	single nucleotide variant	not specified [RCV004372410]	Chr17:30464690 [GRCh38] Chr17:28791708 [GRCh37] Chr17:17q11.2	uncertain significance
NC_000017.10:g.(?_28524804)_(29624377_?)del	deletion	Neurofibromatosis, type 1 [RCV004579908]	Chr17:28524804..29624377 [GRCh37] Chr17:17q11.2	pathogenic
NM_001304.5(CPD):c.2606C>G (p.Thr869Arg)	single nucleotide variant	not specified [RCV004610980]	Chr17:30445753 [GRCh38] Chr17:28772771 [GRCh37] Chr17:17q11.2	uncertain significance
NM_001304.5(CPD):c.1604C>T (p.Ser535Leu)	single nucleotide variant	not specified [RCV004610979]	Chr17:30422970 [GRCh38] Chr17:28749988 [GRCh37] Chr17:17q11.2	uncertain significance
NM_001304.5(CPD):c.2689C>G (p.Pro897Ala)	single nucleotide variant	not specified [RCV004910466]	Chr17:30445836 [GRCh38] Chr17:28772854 [GRCh37] Chr17:17q11.2	uncertain significance
NM_001304.5(CPD):c.1257C>G (p.Phe419Leu)	single nucleotide variant	not specified [RCV004910470]	Chr17:30421783 [GRCh38] Chr17:28748801 [GRCh37] Chr17:17q11.2	uncertain significance
NM_001304.5(CPD):c.873G>T (p.Leu291Phe)	single nucleotide variant	not specified [RCV004910475]	Chr17:30385115 [GRCh38] Chr17:28712133 [GRCh37] Chr17:17q11.2	uncertain significance
NM_001304.5(CPD):c.3787G>A (p.Ala1263Thr)	single nucleotide variant	not specified [RCV004910473]	Chr17:30462033 [GRCh38] Chr17:28789051 [GRCh37] Chr17:17q11.2	uncertain significance
NM_001304.5(CPD):c.3996T>A (p.Asp1332Glu)	single nucleotide variant	not specified [RCV004910481]	Chr17:30464667 [GRCh38] Chr17:28791685 [GRCh37] Chr17:17q11.2	uncertain significance
NM_001304.5(CPD):c.2281A>G (p.Ile761Val)	single nucleotide variant	not specified [RCV004910469]	Chr17:30442358 [GRCh38] Chr17:28769376 [GRCh37] Chr17:17q11.2	uncertain significance
NM_001304.5(CPD):c.3285A>T (p.Leu1095Phe)	single nucleotide variant	not specified [RCV004910474]	Chr17:30455418 [GRCh38] Chr17:28782436 [GRCh37] Chr17:17q11.2	uncertain significance
NM_001304.5(CPD):c.2897G>A (p.Arg966His)	single nucleotide variant	not specified [RCV004910477]	Chr17:30449576 [GRCh38] Chr17:28776594 [GRCh37] Chr17:17q11.2	uncertain significance
NM_001304.5(CPD):c.3158T>C (p.Ile1053Thr)	single nucleotide variant	not specified [RCV004910465]	Chr17:30451799 [GRCh38] Chr17:28778817 [GRCh37] Chr17:17q11.2	likely benign
NM_001304.5(CPD):c.943G>A (p.Glu315Lys)	single nucleotide variant	not specified [RCV004910471]	Chr17:30385185 [GRCh38] Chr17:28712203 [GRCh37] Chr17:17q11.2	uncertain significance
NM_001304.5(CPD):c.737G>A (p.Arg246His)	single nucleotide variant	not specified [RCV004910480]	Chr17:30379717 [GRCh38] Chr17:28706735 [GRCh37] Chr17:17q11.2	uncertain significance
NM_001304.5(CPD):c.481C>T (p.Arg161Cys)	single nucleotide variant	not specified [RCV004910467]	Chr17:30379461 [GRCh38] Chr17:28706479 [GRCh37] Chr17:17q11.2	uncertain significance
NM_001304.5(CPD):c.1088G>A (p.Arg363Gln)	single nucleotide variant	not specified [RCV004910468]	Chr17:30420934 [GRCh38] Chr17:28747952 [GRCh37] Chr17:17q11.2	uncertain significance
NM_001304.5(CPD):c.721C>T (p.Leu241Phe)	single nucleotide variant	not specified [RCV004910476]	Chr17:30379701 [GRCh38] Chr17:28706719 [GRCh37] Chr17:17q11.2	uncertain significance
NM_001304.5(CPD):c.1145T>C (p.Ile382Thr)	single nucleotide variant	not specified [RCV004910478]	Chr17:30421671 [GRCh38] Chr17:28748689 [GRCh37] Chr17:17q11.2	uncertain significance
NM_001304.5(CPD):c.3176G>A (p.Arg1059His)	single nucleotide variant	not specified [RCV004910479]	Chr17:30451817 [GRCh38] Chr17:28778835 [GRCh37] Chr17:17q11.2	likely benign
NM_001304.5(CPD):c.1436C>T (p.Thr479Ile)	single nucleotide variant	not specified [RCV004897628]	Chr17:30422802 [GRCh38] Chr17:28749820 [GRCh37] Chr17:17q11.2	uncertain significance

Predicted Target Of

	Summary Value
Count of predictions:	2890
Count of miRNA genes:	1153
Interacting mature miRNAs:	1451
Transcripts:	ENST00000225719, ENST00000543464, ENST00000579502, ENST00000580396, ENST00000581826, ENST00000583275, ENST00000584050, ENST00000584051, ENST00000584221, ENST00000588977
Prediction methods:	Miranda, Rnahybrid, Targetscan
Result types:	miRGate_prediction

The detailed report is available here: Full Report CSV TAB Printer

miRNA Target Status data imported from miRGate (http://mirgate.bioinfo.cnio.es/).
For more information about miRGate, see PMID:25858286 or access the full paper here.

The following QTLs overlap with this region.

RGD ID	Symbol	Name	LOD	P Value	Trait	Sub Trait	Chr	Start	Stop	Species
597619839	GWAS1676699_H	mental or behavioural disorder QTL GWAS1676699 (human)		3e-12	mental or behavioural disorder		17	30388536	30388537	Human
1298406	BP16_H	Blood pressure QTL 16 (human)		0.0004	Blood pressure	hypertension susceptibility	17	14778647	40778647	Human
597392542	GWAS1488616_H	high density lipoprotein cholesterol measurement QTL GWAS1488616 (human)		4e-13	high density lipoprotein cholesterol measurement	blood high density lipoprotein cholesterol level (CMO:0000052)	17	30454774	30454775	Human
597339004	GWAS1435078_H	respiratory failure, COVID-19 QTL GWAS1435078 (human)		0.0000009	respiratory failure, COVID-19		17	30409086	30409087	Human
597505028	GWAS1601102_H	high density lipoprotein cholesterol measurement QTL GWAS1601102 (human)		3e-08	high density lipoprotein cholesterol measurement	blood high density lipoprotein cholesterol level (CMO:0000052)	17	30454774	30454775	Human
597457286	GWAS1553360_H	high density lipoprotein cholesterol measurement QTL GWAS1553360 (human)		9e-10	high density lipoprotein cholesterol measurement	blood high density lipoprotein cholesterol level (CMO:0000052)	17	30454774	30454775	Human
597058938	GWAS1155012_H	BMI-adjusted waist-hip ratio QTL GWAS1155012 (human)		6e-10	body size trait (VT:0100005)		17	30422242	30422243	Human
597339591	GWAS1435665_H	sexual dimorphism measurement QTL GWAS1435665 (human)		3e-10	sexual dimorphism measurement		17	30453515	30453516	Human
597208374	GWAS1304448_H	mathematical ability QTL GWAS1304448 (human)		5e-08	mathematical ability		17	30393723	30393724	Human
597492371	GWAS1588445_H	sexual dimorphism measurement QTL GWAS1588445 (human)		9e-09	sexual dimorphism measurement		17	30454774	30454775	Human

D17S2009

Human Assembly	Chr	Position (strand)	Source	JBrowse
GRCh37	17	28,792,167 - 28,792,296	UniSTS	GRCh37
Build 36	17	25,816,293 - 25,816,422	RGD	NCBI36
Celera	17	25,653,667 - 25,653,796	RGD
Cytogenetic Map	17	q11.2	UniSTS
HuRef	17	25,002,196 - 25,002,325	UniSTS
Whitehead-YAC Contig Map	17		UniSTS

RH11489

Human Assembly	Chr	Position (strand)	Source	JBrowse
GRCh37	17	28,793,259 - 28,793,408	UniSTS	GRCh37
Build 36	17	25,817,385 - 25,817,534	RGD	NCBI36
Celera	17	25,654,759 - 25,654,908	RGD
Cytogenetic Map	17	q11.2	UniSTS
HuRef	17	25,003,288 - 25,003,437	UniSTS

RH47227

Human Assembly	Chr	Position (strand)	Source	JBrowse
GRCh37	17	28,794,504 - 28,794,652	UniSTS	GRCh37
Build 36	17	25,818,630 - 25,818,778	RGD	NCBI36
Celera	17	25,656,004 - 25,656,152	RGD
Cytogenetic Map	17	q11.2	UniSTS
HuRef	17	25,004,533 - 25,004,681	UniSTS

RH104247

Human Assembly	Chr	Position (strand)	Source	JBrowse
GRCh37	17	28,761,839 - 28,762,011	UniSTS	GRCh37
Build 36	17	25,785,965 - 25,786,137	RGD	NCBI36
Celera	17	25,623,333 - 25,623,505	RGD
Cytogenetic Map	17	q11.2	UniSTS
HuRef	17	24,971,865 - 24,972,037	UniSTS

STS-H01467

Human Assembly	Chr	Position (strand)	Source	JBrowse
GRCh37	17	28,795,512 - 28,795,641	UniSTS	GRCh37
GRCh37	8	124,561,401 - 124,562,606	UniSTS	GRCh37
Build 36	17	25,819,638 - 25,819,767	RGD	NCBI36
Celera	8	120,749,058 - 120,750,262	UniSTS
Celera	17	25,657,012 - 25,657,141	RGD
Cytogenetic Map	17	q11.2	UniSTS
HuRef	17	25,005,541 - 25,005,670	UniSTS
HuRef	8	119,887,001 - 119,888,205	UniSTS
GeneMap99-GB4 RH Map	17	271.89	UniSTS

CPD_1887

Human Assembly	Chr	Position (strand)	Source	JBrowse
GRCh37	17	28,794,964 - 28,795,775	UniSTS	GRCh37
Build 36	17	25,819,090 - 25,819,901	RGD	NCBI36
Celera	17	25,656,464 - 25,657,275	RGD
HuRef	17	25,004,993 - 25,005,804	UniSTS

A001U18

Human Assembly	Chr	Position (strand)	Source	JBrowse
GRCh37	17	28,794,494 - 28,794,613	UniSTS	GRCh37
Build 36	17	25,818,620 - 25,818,739	RGD	NCBI36
Celera	17	25,655,994 - 25,656,113	RGD
Cytogenetic Map	17	q11.2	UniSTS
HuRef	17	25,004,523 - 25,004,642	UniSTS
GeneMap99-GB4 RH Map	17	271.56	UniSTS

D17S962E

Human Assembly	Chr	Position (strand)	Source	JBrowse
GRCh37	17	28,762,738 - 28,762,884	UniSTS	GRCh37
Build 36	17	25,786,864 - 25,787,010	RGD	NCBI36
Celera	17	25,624,232 - 25,624,378	RGD
HuRef	17	24,972,764 - 24,972,910	UniSTS

D17S2004

Human Assembly	Chr	Position (strand)	Source	JBrowse
GRCh37	17	28,794,073 - 28,794,179	UniSTS	GRCh37
Build 36	17	25,818,199 - 25,818,305	RGD	NCBI36
Celera	17	25,655,573 - 25,655,679	RGD
Cytogenetic Map	17	q11.2	UniSTS
HuRef	17	25,004,102 - 25,004,208	UniSTS
Whitehead-YAC Contig Map	17		UniSTS

MARC_23481-23482:1027350718:1

Human Assembly	Chr	Position (strand)	Source	JBrowse
HuRef	17	24,999,050 - 24,999,489	UniSTS

Click on a value in the shaded box below the category label to view a detailed expression data table for that system.

Download All Expressed Objects for this Gene

adipose tissue	alimentary part of gastrointestinal system	appendage	circulatory system	ectoderm	endocrine system	endoderm	entire extraembryonic component	exocrine system	hemolymphoid system	hepatobiliary system	integumental system	mesenchyme	mesoderm	musculoskeletal system	nervous system	pharyngeal arch	renal system	reproductive system	respiratory system	sensory system	visual system
1204	2439	2788	2253	4974	1726	2351	6	624	1951	465	2270	7306	6472	53	3734	1	852	1744	1617	175	1


RefSeq Transcripts	NM_001199775	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	NM_001304	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
GenBank Nucleotide	AC006050	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	AC090685	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	AK302497	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	AK302878	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	AK316409	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	AL049339	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	BC020457	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	BC045549	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	BC045624	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	BC051702	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	BC054116	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	BX648887	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	CA436219	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	CH471159	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	CP068261	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	D85390	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	U65090	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	U90914	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles

Ensembl Acc Id:

ENST00000225719 ⟹ ENSP00000225719

Type:

CODING

Position:

Human Assembly	Chr	Position (strand)	Source
GRCh38.p14 Ensembl	17	30,378,927 - 30,469,989 (+)	Ensembl

Ensembl Acc Id:

ENST00000543464 ⟹ ENSP00000444443

Type:

CODING

Position:

Human Assembly	Chr	Position (strand)	Source
GRCh38.p14 Ensembl	17	30,380,236 - 30,465,017 (+)	Ensembl

Ensembl Acc Id:

ENST00000579502 ⟹ ENSP00000464255

Type:

CODING

Position:

Human Assembly	Chr	Position (strand)	Source
GRCh38.p14 Ensembl	17	30,451,810 - 30,464,947 (+)	Ensembl

Ensembl Acc Id:

ENST00000580396

Type:

CODING

Position:

Human Assembly	Chr	Position (strand)	Source
GRCh38.p14 Ensembl	17	30,454,021 - 30,456,863 (+)	Ensembl

Ensembl Acc Id:

ENST00000581826

Type:

CODING

Position:

Human Assembly	Chr	Position (strand)	Source
GRCh38.p14 Ensembl	17	30,438,985 - 30,444,144 (+)	Ensembl

Ensembl Acc Id:

ENST00000583275

Type:

CODING

Position:

Human Assembly	Chr	Position (strand)	Source
GRCh38.p14 Ensembl	17	30,379,616 - 30,385,292 (+)	Ensembl

Ensembl Acc Id:

ENST00000584050 ⟹ ENSP00000466049

Type:

CODING

Position:

Human Assembly	Chr	Position (strand)	Source
GRCh38.p14 Ensembl	17	30,449,673 - 30,456,351 (+)	Ensembl

Ensembl Acc Id:

ENST00000584051

Type:

CODING

Position:

Human Assembly	Chr	Position (strand)	Source
GRCh38.p14 Ensembl	17	30,450,236 - 30,461,266 (+)	Ensembl

Ensembl Acc Id:

ENST00000584221 ⟹ ENSP00000463763

Type:

CODING

Position:

Human Assembly	Chr	Position (strand)	Source
GRCh38.p14 Ensembl	17	30,443,802 - 30,466,423 (+)	Ensembl

Ensembl Acc Id:

ENST00000588977

Type:

CODING

Position:

Human Assembly	Chr	Position (strand)	Source
GRCh38.p14 Ensembl	17	30,445,691 - 30,451,737 (+)	Ensembl

RefSeq Acc Id:

NM_001199775 ⟹ NP_001186704

RefSeq Status:

REVIEWED

Type:

CODING

Position:

Human Assembly	Chr	Position (strand)	Source
GRCh38	17	30,380,478 - 30,469,657 (+)	NCBI
GRCh37	17	28,705,942 - 28,796,675 (+)	ENTREZGENE
HuRef	17	24,915,981 - 25,006,704 (+)	ENTREZGENE
CHM1_1	17	28,769,728 - 28,859,153 (+)	NCBI
T2T-CHM13v2.0	17	31,325,109 - 31,414,283 (+)	NCBI

Sequence:

show sequence

ATTTGTGCACCTTATTAGCCTGGGCAGAATGGCTAATGGTCACACTTCTAATACACACTTTAAGTGTTATTAAGCATTGCATGAGGTTTAAAAAATTACAAAGTAGAAGAAGGAGGACCTCAAGAAAT
TAGTATAAAACAAGAGAATGTTATAAATATTTATGAGGTTTGTGCTTTCTGGAAATCTGCATGGTGGCTCAGTGGTAGCAAGCTATCCTTTTGATGATTCTCCAGAACATAAGGCCACTGGAATCTAT
AGCAAAACCTCAGATGATGAAGTATTTAAATACTTGGCAAAAGCTTATGCTTCAAACCACCCCATAATGAAAACTGGTGAGCCTCATTGTCCAGGAGATGAAGACGAGACTTTCAAAGATGGAATCAC
AAACGGCGCACATTGGTATGATGTGGAAGGTGGTATGCAAGATTACAATTATGTGTGGGCCAACTGTTTTGAGATCACATTAGAACTGTCTTGTTGCAAGTACCCACCTGCTTCACAGCTTCGACAGG
AATGGGAGAACAATCGTGAGTCTTTGATCACATTGATTGAAAAGGTTCACATTGGAGTGAAAGGATTTGTTAAAGATTCCATAACAGGATCTGGGTTAGAGAATGCAACCATCTCAGTGGCTGGTATT
AATCATAATATCACAACAGGCAGATTTGGTGATTTCTACCGATTACTTGTTCCTGGAACTTACAACCTTACAGTAGTTTTAACTGGGTATATGCCATTGACTGTTACTAATGTAGTGGTGAAAGAAGG
ACCAGCCACAGAGGTGGATTTTTCTCTTAGGCCAACTGTAACTTCAGTAATCCCTGACACGACAGAGGCTGTATCAACTGCTAGCACAGTTGCTATACCTAATATTCTTTCTGGAACATCATCCTCCT
ACCAGCCAATTCAGCCAAAGGACTTTCACCACCACCATTTCCCTGATATGGAAATCTTCTTGAGAAGGTTTGCCAATGAATATCCTAACATTACCCGGCTTTATTCCTTGGGAAAATCAGTAGAGTCA
AGAGAACTTTATGTGATGGAGATATCTGATAATCCGGGTGTCCATGAACCAGGTGAACCAGAATTTAAGTACATTGGAAATATGCATGGAAATGAAGTGGTTGGAAGAGAACTGCTGTTGAACCTCAT
AGAATACCTTTGTAAGAACTTTGGAACAGACCCTGAAGTCACAGATTTGGTTCATAACACTAGAATTCACCTTATGCCATCCATGAATCCTGATGGGTATGAAAAGTCCCAGGAAGGAGATTCAATAA
GTGTAATTGGCAGAAACAACAGCAACAACTTTGACCTGAACCGAAATTTCCCAGACCAGTTTGTTCAGATCACAGATCCTACGCAACCAGAAACTATTGCTGTAATGAGCTGGATGAAGTCCTATCCA
TTTGTACTTTCAGCAAACCTGCATGGAGGTTCTTTGGTGGTTAACTACCCTTTTGATGATGATGAACAAGGACTTGCCACATATAGTAAATCACCAGATGATGCTGTGTTCCAACAAATAGCACTTTC
TTATTCCAAGGAAAATTCCCAGATGTTTCAAGGTAGACCTTGCAAGAATATGTATCCTAATGAATATTTTCCTCATGGAATAACAAATGGAGCTAGTTGGTATAATGTGCCAGGAGGAATGCAGGACT
GGAACTATTTACAAACAAATTGCTTTGAAGTGACTATTGAACTAGGTTGTGTGAAATATCCACTTGAGAAAGAGCTGCCAAACTTTTGGGAACAGAATCGAAGATCACTAATCCAGTTTATGAAACAG
GTTCATCAGGGCGTCAGAGGATTTGTTCTAGATGCCACAGATGGCAGGGGTATATTAAATGCCACCATTAGTGTTGCTGAGATTAATCACCCAGTGACTACTTACAAAACTGGAGATTACTGGCGTCT
CTTGGTTCCAGGAACTTATAAAATCACAGCATCTGCTCGAGGGTATAATCCAGTTACCAAGAATGTGACTGTCAAGAGTGAAGGCGCTATTCAGGTCAACTTCACACTTGTTCGATCCTCAACAGATT
CAAACAATGAATCAAAGAAAGGAAAAGGGGCTAGCAGCAGCACCAATGATGCCAGTGATCCAACTACTAAAGAGTTTGAAACTTTAATTAAAGACCTTTCAGCGGAGAATGGTTTGGAAAGCCTCATG
TTACGCTCCTCCTCAAATCTGGCTCTGGCTCTTTATCGATACCATTCCTACAAAGACTTATCAGAGTTTCTGAGAGGACTTGTAATGAACTATCCACATATTACAAATCTTACCAATTTGGGACAGAG
CACTGAATATCGTCACATTTGGTCCCTTGAAATCTCCAATAAGCCCAATGTATCTGAGCCTGAAGAACCAAAGATTCGTTTTGTTGCTGGTATCCATGGAAATGCGCCAGTTGGAACTGAACTGCTTT
TGGCTCTGGCAGAATTTCTCTGCCTGAACTACAAAAAGAACCCAGCTGTTACCCAATTGGTTGACAGGACTAGGATTGTGATTGTCCCTTCTCTAAATCCAGATGGGCGAGAGAGAGCTCAAGAGAAA
GACTGTACTTCAAAAATAGGACAAACAAATGCTCGTGGCAAAGATTTGGATACAGACTTCACAAATAATGCCTCCCAACCTGAGACCAAAGCCATCATTGAAAATTTGATTCAAAAACAGGACTTTAG
TCTTTCTGTTGCCTTAGATGGTGGTTCCATGCTGGTCACATATCCTTATGACAAGCCAGTACAGACAGTGGAAAATAAAGAGACTCTGAAGCATTTGGCATCTCTTTATGCAAATAATCATCCATCCA
TGCACATGGGTCAGCCCAGTTGCCCAAATAAATCAGATGAGAATATTCCAGGAGGAGTAATGCGTGGAGCAGAATGGCATAGTCACCTGGGCAGCATGAAGGATTATAGTGTCACCTATGGCCATTGT
CCGGAAATCACAGTATACACAAGCTGCTGTTACTTTCCTAGTGCTGCACGACTCCCTTCCTTGTGGGCAGACAATAAGAGATCTCTTCTTAGTATGTTAGTGGAGGTTCACAAGGGAGTTCATGGATT
TGTTAAAGATAAGACTGGAAAGCCAATCTCTAAAGCAGTCATTGTACTTAATGAAGGAATAAAGGTACAAACAAAAGAGGGAGGTTATTTCCATGTACTCTTAGCGCCAGGTGTCCATAACATTATTG
CCATCGCTGATGGGTACCAGCAACAACATTCACAGGTCTTTGTGCATCATGATGCAGCTAGTTCTGTGGTGATAGTCTTTGACACAGATAACCGGATATTTGGTTTGCCAAGGGAGCTTGTGGTAACT
GTATCAGGTGCTACTATGTCGGCATTGATCCTAACAGCTTGCATTATTTGGTGCATCTGCTCAATCAAGTCTAATAGACACAAGGATGGCTTTCATCGGCTCAGGCAGCATCATGATGAGTATGAAGA
TGAAATTCGCATGATGTCTACCGGCTCCAAGAAGTCCCTCCTAAGCCATGAGTTCCAGGATGAAACAGACACTGAAGAGGAAACATTATATTCTAGCAAACATTGAAAAACACATTTTGCATATCTCC
CAGCATAAGTACCAAGCAAAATTACAGTTCCTCTTGGGAGAACACTGCATTAAGAAGAGAGACTCTCTTGCTTCTTCAAAGAGCTTTGGGAAATTAAATTGCTAAATTTGTATTCTCTGTGAATTTCA
CTGGCAGTTTTGAACTTCCCTTCCTTAAAGTACTCTAAACCTTTAAAAAAAAATCTGATTTATGCAGCAGAGATGGGACAGCCACTTTTTCTTTTTAATTTAAGATGAGCTATTTGGAGCTTATGTAA
TAATGGCATAAAGCCAACTAGAGGATGTTGTATTTTGCACATCAGATGTTTACTAGTGGCTTTAGTATTTTTCTTTGTTTTAAATGGCCAAAAGAATCCAGAAACATTAAGGCAGGGACAGCAGTCAG
AATCGACATAAAGCTTTAAAAACTCAAGGTTTTTTCAACCTACTGAGGAGTACTTTTCTCTAGTTGTTAAATAGCTGGAGTTTTTCTTATTCAGGTTTAATGGAGGTTGAATTGATTTTTAAACACAT
ATAACAGTAGGAAATGAATAAATGGGCTTCTGCATTTGGCTTTCTACCTGTTCCAAGGCTAGATCGGAACTGGTAGACTACGCTGTAAGCAGGATTTCACTACCTCTCTTAAGGTTTAGCAAACTTCT
AAATAGCCCATTTTAAGGGAGAACTTACTAACTTTATTGTGAAAGGTCTAAATGCCCACTTGAATGAAGCTGAGAGAGAGATCTAGCAAAAGCTAAAACTCATGTTGTCTATCTTTGAACTTGGTAAA
AACCCACAGGTGCTGCTGCTTATATCTGTGAAGCACTAGCTTATTCTAGGAATGCCTGATTCTTTAATATTGCCTAAATCGGAACCTTTTTCTATGTTGCACACATGGTTTTCAGATGACCCAGCCAT
CTACAAGATCTGAATTCTACTGAAAATATCTAGAAATGTGGAAGAGACCTACTTGCACATTCTTAACCTGTATTTGAACACAAAATATCTATACTTCATGCTCCAGCCCAAGCCTATACCCTGTAATA
GCATACTATTATTGAAATCGCTTGACCGGTCTTGTTCACATAGGCCTCTGGGAGTGATTTGGTTCTTTGCCCTAATGTTTCATTTGACGGTCTCTTTTTGATCAACCAATTTTTCTAAAAGTTCAGTC
GAAAGCTTTTAAGTATAGCTTCCTCCCTTGAAAAAAAATGTAAACTATGACTGCTGAGTGATAAAACACTGTGGTGTGAAAGTGTCATCTTCACTGCCAATCAGGCAAAGACCGGAAAGATTTGCATT
TTATTATGTCTGTCTTATCATGCAATGGAAATGATGCTTTTTGTAAGTATGCATCTTACCAATGATGTAACGGTTTAATACCTTTGAATGTTTTAATAACCAAGTTGCTGCTGAACTTATACTAAATC
AGGGGACCAAAAAACTTGCTCTTATCTTCTCAAATTGTATTCTATATCCATTAATGTATCAGTTATCCCAAAGCCTTCAGGTGGAGGGGTTTACCACCTTCCTAGGTCGTTCAACCAGGTTTTGTGAG
GAATGCATTCAAAGTGGCTTTATAAAAGAAGATTTTCTTTAGCAAGAATAATGAGGTCATGTCATTTGTTAATAAGTATCTGTGATAAATCCGTGGTTCAAGGTTAAGCCATTCTGGTATTCTGGTAT
TAGCAACTGTAAATTCTGCCACCTCATACATGGAACAGAGCTTGTGGGATGCTAATAGTTAGTGAAGTATACATGATTTAATTTCTAATAATCTTTATGTTTTCTTTAAGGATGGTGGTGTATTGCTC
TTTTTCAGCTTTATTTTTAAGAGTACAGTCAGGAAACCAACAAGGGGCCTAAGAGTGGCTGCCCCTGCTTGGGACATTACAGCAAGTGAAACAAAGTTAATGTGACAAGCTTTGCTTTGTTATCATTG
GTCTTCACTAGAGGATACCTTTTACATGTACTTCTCTCTTGGATCAAATATGTCTTTAACTGTACATCTCAGTGGCTGGAGGCCATGCCTTTTAAGCATGTGTAAAATTTTTAAAGAAATGAACATAC
ACATAGTTATTTTAGTAATATTTCCTGAAAGAAAAACCAAATTCTGCTATAAGTCTTGATCTTCAATGAACTTTTAAATAATGCATTTAGCTGGAAAACAAGACTTTCCCAGCTTGTATTACCTAGAA
GCGTGAATGTATAGGATACCTGACTACTAAGACTATATTCTCAGCCCTGCCCTGTCTTTTATTTGCGGGTCTAATCTAATATTAGAATATATTAACCGCTTAAGGCATTGAAGCCATATGGGATGGGG
AATGCATTTCTTCAGTGTTTCTCCGAGAGACTTTCCATTTCCTTGGAGTTATGGCGGCAAGTAAGTATCATAGTATTAAGAAATTTGCCTAAATCTGAGTTGTGCCTTTCTTTACTCACAAGGCATGG
GCTTTGTCCTGGTGATCAGTTTGTAAGCCTTCTTCCTTCCCAGCTCCTTAATAAAAGCAAAGTGATTGAGTAGGTAATGTTCAAAGTGTCTGCCTGTGTACATGTACTTGTATTGATTATGTAGTTCA
GTAAGATGTGCCCAAGTCATTTCAGAAAGAAAGACCCTTCAGTTTTGATGCATTTTGCTGAACACTTGGGTAGTGAGTGGGATCCTATCCAGTTGAGGAATGCTTGCAATGCTCATTGAAGGGATTTG
CTTTGGGACTTTGTCATCTTCCAGAAAGGAAACATATTGTATATTTGGCCCAGTGTGATTGATTGCTTTATCTTTGGTAACTTTTACTTGAATGGGATTTGCTGAATTAATGACTATTGAATTTAAAA
CTAATTATGAGTTGACAAATAAATAAAAGGTAGTGTTTATGTCTGAGCTTATTGTGTTTGAGCTAACACCAGGTTACTCAGTAACCATGACCTGCTCCTCCATTTCCATTTATTCTCAACATTAAATA
GTTTTATCTTGTTGTTGCCAGAAATGCACTTGTGCCAGGTATTGTCCCTGCTGTATGAAAAGCTTCTTGGCAATGAATTCTGTAATAGTGCCCTACATTATGGTTTTCTGGTGGAATTGTTTTAACAG
TGACAACCCAGGATTTCCAATATATTTTTGTTTTATTGTTATTACCAAAAATTCCACTATGATTGATGTTCAGTGATTTTCTATAGCAACTTTTTTGGTAACTCTTTGGGTTTCTGATTTGTTTTAGC
TAAAATTTTGGGGATATGATTTGGGTCTTTGATTAATGTCAGCTGAACTTGGATTTCTAGTTCATGAAGAAATCTCTCCCAATACCCATTTATCCTATTTTTAGCAATAATTCGTTAATGATTCCACT
TGATTTTCAGAATATTGTCCTGGTTGATTTTGATTTGACAGCATACATTATGAAATTTGAAAGTAGGTTACCATTTTGAGGCAGTTGGATATAAATTATGTAAATATGTATGATTATGATTTTTATAA
ATGGCATAACATGAGTGTACTAACTACCTTCTATGCTGGCCATGCTACAGATTTTCTGGAGGTATGACAATAGTATTTTTTTATGCTCAGATTAAAAATCAGCTTTTCACCTCTCCAGTTTTTCCAAG
TGATACTCCCAGTTCTAGAGCAATCTACAGCTGTTTATGTGAGGTGCCCAACACCCATTCATCTCAAGTGCTTCAGTCTTTGGTTTATTTCATGCACTGTGCCTTCAAAATGAAATTTTTAAAAGGGA
CTTTAAATGAAGTTGAATAGTAGTTTTTAAAAGTCAATTTGTAATTTATGTGAAATCTAACTGTAATGAGGTCCTTTCTGTTTTTTATATGTAAACAGATCTACTAATCCTGTATAAAAGTTATTTTA
CGATGTTTGTCTTTCTTTGTGTTTTGTCTCATAATCTTTTTTCAGATGCAATATGCCGGAAAAAGTTATAGGTCCAGTTTGAAAATTATTTAGTTTTTCTGCCTATGCTAGTGGAAAAATAGTACCAG
GATCAGAATACAGGGTATCACCTATGGAATGTTTCTGTATTTATGAATTGACTCAAAAGAAAGCTTTGTTTCTGAAATCGCATTATGTAGTAGCCACAGTTTTCTGTTTGTAGCTCAGCTAGATTGTT
ATATATGTTCAATCATTTCACAATAACAACACAAAACTGGTCATTGAAAGGTTTTTATGTACGCATTTTAAACTTGTTCGTTAAAAATTTGGTCCTTTTTCCAGGTGAGGCCCAGTTAGAATAATGTG
TCCCGGCACTTTTAGGCACAGCAAGGATGAATTCAATATCCCCTTTTCACTTAGCAACAATGTGTTACTTCTACCCTAATAGGAATTGGGAAAGCAAAGTTGTATGAGAAACAGACTCTGCTGATAAA
GTACTCATAGTCCAGACCAGAGAAATATAAATGGAAATAGGTTATATTTCAATAGTGATTGGTTCATCTAAAAGTCTCTGCTGTAAAGGAAATAAAGCATAGAGGTTTGAGCATGGACTTTGGAGTTG
GACCAATCTGTGACTGATTCTTCGTTCTGCTACTTGCTTCCAATGTGACCTTGTACAAGTTTCTTGACATTCTCTGAGCCTCAGTTTCTCTACTGGTTGAATAATCCTTGATAGGATTGCAGTGGAAA
ATTAAATGAAATAATGTTAGCAAAGGTCCCAACATAATATTTGACTTGGAATTGAATGCCCATGGTAACCAGCATCATTTTCCTTCATGTGATGTCTTCTTATGCCTTTGAAAGAAAGTTACTTTATC
AAATGTATAAATAAAGATCTGTTTATAGGTGATCTTTTTAATTTAGAAGAAATTCTGAGACACAAATAAAAAAAGAAATTTTTTAAAAAAAAAAAAAAAAAA

hide sequence

RefSeq Acc Id:

NM_001304 ⟹ NP_001295

RefSeq Status:

REVIEWED

Type:

CODING

Position:

Human Assembly	Chr	Position (strand)	Source
GRCh38	17	30,378,927 - 30,469,989 (+)	NCBI
GRCh37	17	28,705,942 - 28,796,675 (+)	ENTREZGENE
Build 36	17	25,730,110 - 25,819,825 (+)	NCBI Archive
HuRef	17	24,915,981 - 25,006,704 (+)	ENTREZGENE
CHM1_1	17	28,768,174 - 28,859,153 (+)	NCBI
T2T-CHM13v2.0	17	31,323,558 - 31,414,615 (+)	NCBI

Sequence:

show sequence

GCCCGGAGCGCTGAGCCGCGGGAGCGGAGCCGGGGTTAGCGGCGCTGCTGGAAGATGGCGAGCGGCCGGGACGAGCGGCCGCCTTGGCGGCTAGGGCGGCTCCTGTTGCTCATGTGCCTGCTGCTGCT
GGGGAGCTCGGCCCGGGCGGCTCACATCAAGAAGGCGGAGGCGACTACCACAACTACGAGCGCGGGCGCCGAGGCGGCCGAGGGCCAGTTCGACCGCTACTACCACGAAGAGGAGTTGGAGTCGGCGC
TGAGGGAGGCGGCGGCCGCGGGCCTCCCCGGCCTGGCCCGCCTCTTTAGCATCGGCCGCTCGGTGGAAGGCCGGCCGCTGTGGGTGCTTCGCCTCACCGCCGGCCTGGGGTCGCTAATCCCTGAGGGC
GACGCGGGGCCTGACGCTGCCGGGCCCGACGCTGCGGGGCCGCTGCTGCCCGGCCGGCCCCAGGTGAAGCTGGTGGGCAACATGCATGGCGACGAGACCGTGTCGCGCCAGGTGTTGATCTACTTGGC
CCGCGAGCTGGCGGCCGGCTACCGCCGCGGGGACCCGCGCCTGGTCCGCCTGCTCAACACCACCGACGTGTACCTGCTGCCCAGCCTCAACCCCGATGGCTTCGAGCGTGCCCGCGAGGGCGACTGTG
GCTTCGGCGACGGCGGCCCGTCCGGGGCCAGCGGCCGCGACAATAGTCGCGGCCGCGACCTCAACCGAAGCTTTCCCGACCAGTTTAGCACCGGCGAACCCCCCGCCCTGGACGAGGTGCCCGAGGTG
CGCGCCCTCATCGAGTGGATCCGCAGGAACAAGTTTGTGCTTTCTGGAAATCTGCATGGTGGCTCAGTGGTAGCAAGCTATCCTTTTGATGATTCTCCAGAACATAAGGCCACTGGAATCTATAGCAA
AACCTCAGATGATGAAGTATTTAAATACTTGGCAAAAGCTTATGCTTCAAACCACCCCATAATGAAAACTGGTGAGCCTCATTGTCCAGGAGATGAAGACGAGACTTTCAAAGATGGAATCACAAACG
GCGCACATTGGTATGATGTGGAAGGTGGTATGCAAGATTACAATTATGTGTGGGCCAACTGTTTTGAGATCACATTAGAACTGTCTTGTTGCAAGTACCCACCTGCTTCACAGCTTCGACAGGAATGG
GAGAACAATCGTGAGTCTTTGATCACATTGATTGAAAAGGTTCACATTGGAGTGAAAGGATTTGTTAAAGATTCCATAACAGGATCTGGGTTAGAGAATGCAACCATCTCAGTGGCTGGTATTAATCA
TAATATCACAACAGGCAGATTTGGTGATTTCTACCGATTACTTGTTCCTGGAACTTACAACCTTACAGTAGTTTTAACTGGGTATATGCCATTGACTGTTACTAATGTAGTGGTGAAAGAAGGACCAG
CCACAGAGGTGGATTTTTCTCTTAGGCCAACTGTAACTTCAGTAATCCCTGACACGACAGAGGCTGTATCAACTGCTAGCACAGTTGCTATACCTAATATTCTTTCTGGAACATCATCCTCCTACCAG
CCAATTCAGCCAAAGGACTTTCACCACCACCATTTCCCTGATATGGAAATCTTCTTGAGAAGGTTTGCCAATGAATATCCTAACATTACCCGGCTTTATTCCTTGGGAAAATCAGTAGAGTCAAGAGA
ACTTTATGTGATGGAGATATCTGATAATCCGGGTGTCCATGAACCAGGTGAACCAGAATTTAAGTACATTGGAAATATGCATGGAAATGAAGTGGTTGGAAGAGAACTGCTGTTGAACCTCATAGAAT
ACCTTTGTAAGAACTTTGGAACAGACCCTGAAGTCACAGATTTGGTTCATAACACTAGAATTCACCTTATGCCATCCATGAATCCTGATGGGTATGAAAAGTCCCAGGAAGGAGATTCAATAAGTGTA
ATTGGCAGAAACAACAGCAACAACTTTGACCTGAACCGAAATTTCCCAGACCAGTTTGTTCAGATCACAGATCCTACGCAACCAGAAACTATTGCTGTAATGAGCTGGATGAAGTCCTATCCATTTGT
ACTTTCAGCAAACCTGCATGGAGGTTCTTTGGTGGTTAACTACCCTTTTGATGATGATGAACAAGGACTTGCCACATATAGTAAATCACCAGATGATGCTGTGTTCCAACAAATAGCACTTTCTTATT
CCAAGGAAAATTCCCAGATGTTTCAAGGTAGACCTTGCAAGAATATGTATCCTAATGAATATTTTCCTCATGGAATAACAAATGGAGCTAGTTGGTATAATGTGCCAGGAGGAATGCAGGACTGGAAC
TATTTACAAACAAATTGCTTTGAAGTGACTATTGAACTAGGTTGTGTGAAATATCCACTTGAGAAAGAGCTGCCAAACTTTTGGGAACAGAATCGAAGATCACTAATCCAGTTTATGAAACAGGTTCA
TCAGGGCGTCAGAGGATTTGTTCTAGATGCCACAGATGGCAGGGGTATATTAAATGCCACCATTAGTGTTGCTGAGATTAATCACCCAGTGACTACTTACAAAACTGGAGATTACTGGCGTCTCTTGG
TTCCAGGAACTTATAAAATCACAGCATCTGCTCGAGGGTATAATCCAGTTACCAAGAATGTGACTGTCAAGAGTGAAGGCGCTATTCAGGTCAACTTCACACTTGTTCGATCCTCAACAGATTCAAAC
AATGAATCAAAGAAAGGAAAAGGGGCTAGCAGCAGCACCAATGATGCCAGTGATCCAACTACTAAAGAGTTTGAAACTTTAATTAAAGACCTTTCAGCGGAGAATGGTTTGGAAAGCCTCATGTTACG
CTCCTCCTCAAATCTGGCTCTGGCTCTTTATCGATACCATTCCTACAAAGACTTATCAGAGTTTCTGAGAGGACTTGTAATGAACTATCCACATATTACAAATCTTACCAATTTGGGACAGAGCACTG
AATATCGTCACATTTGGTCCCTTGAAATCTCCAATAAGCCCAATGTATCTGAGCCTGAAGAACCAAAGATTCGTTTTGTTGCTGGTATCCATGGAAATGCGCCAGTTGGAACTGAACTGCTTTTGGCT
CTGGCAGAATTTCTCTGCCTGAACTACAAAAAGAACCCAGCTGTTACCCAATTGGTTGACAGGACTAGGATTGTGATTGTCCCTTCTCTAAATCCAGATGGGCGAGAGAGAGCTCAAGAGAAAGACTG
TACTTCAAAAATAGGACAAACAAATGCTCGTGGCAAAGATTTGGATACAGACTTCACAAATAATGCCTCCCAACCTGAGACCAAAGCCATCATTGAAAATTTGATTCAAAAACAGGACTTTAGTCTTT
CTGTTGCCTTAGATGGTGGTTCCATGCTGGTCACATATCCTTATGACAAGCCAGTACAGACAGTGGAAAATAAAGAGACTCTGAAGCATTTGGCATCTCTTTATGCAAATAATCATCCATCCATGCAC
ATGGGTCAGCCCAGTTGCCCAAATAAATCAGATGAGAATATTCCAGGAGGAGTAATGCGTGGAGCAGAATGGCATAGTCACCTGGGCAGCATGAAGGATTATAGTGTCACCTATGGCCATTGTCCGGA
AATCACAGTATACACAAGCTGCTGTTACTTTCCTAGTGCTGCACGACTCCCTTCCTTGTGGGCAGACAATAAGAGATCTCTTCTTAGTATGTTAGTGGAGGTTCACAAGGGAGTTCATGGATTTGTTA
AAGATAAGACTGGAAAGCCAATCTCTAAAGCAGTCATTGTACTTAATGAAGGAATAAAGGTACAAACAAAAGAGGGAGGTTATTTCCATGTACTCTTAGCGCCAGGTGTCCATAACATTATTGCCATC
GCTGATGGGTACCAGCAACAACATTCACAGGTCTTTGTGCATCATGATGCAGCTAGTTCTGTGGTGATAGTCTTTGACACAGATAACCGGATATTTGGTTTGCCAAGGGAGCTTGTGGTAACTGTATC
AGGTGCTACTATGTCGGCATTGATCCTAACAGCTTGCATTATTTGGTGCATCTGCTCAATCAAGTCTAATAGACACAAGGATGGCTTTCATCGGCTCAGGCAGCATCATGATGAGTATGAAGATGAAA
TTCGCATGATGTCTACCGGCTCCAAGAAGTCCCTCCTAAGCCATGAGTTCCAGGATGAAACAGACACTGAAGAGGAAACATTATATTCTAGCAAACATTGAAAAACACATTTTGCATATCTCCCAGCA
TAAGTACCAAGCAAAATTACAGTTCCTCTTGGGAGAACACTGCATTAAGAAGAGAGACTCTCTTGCTTCTTCAAAGAGCTTTGGGAAATTAAATTGCTAAATTTGTATTCTCTGTGAATTTCACTGGC
AGTTTTGAACTTCCCTTCCTTAAAGTACTCTAAACCTTTAAAAAAAAATCTGATTTATGCAGCAGAGATGGGACAGCCACTTTTTCTTTTTAATTTAAGATGAGCTATTTGGAGCTTATGTAATAATG
GCATAAAGCCAACTAGAGGATGTTGTATTTTGCACATCAGATGTTTACTAGTGGCTTTAGTATTTTTCTTTGTTTTAAATGGCCAAAAGAATCCAGAAACATTAAGGCAGGGACAGCAGTCAGAATCG
ACATAAAGCTTTAAAAACTCAAGGTTTTTTCAACCTACTGAGGAGTACTTTTCTCTAGTTGTTAAATAGCTGGAGTTTTTCTTATTCAGGTTTAATGGAGGTTGAATTGATTTTTAAACACATATAAC
AGTAGGAAATGAATAAATGGGCTTCTGCATTTGGCTTTCTACCTGTTCCAAGGCTAGATCGGAACTGGTAGACTACGCTGTAAGCAGGATTTCACTACCTCTCTTAAGGTTTAGCAAACTTCTAAATA
GCCCATTTTAAGGGAGAACTTACTAACTTTATTGTGAAAGGTCTAAATGCCCACTTGAATGAAGCTGAGAGAGAGATCTAGCAAAAGCTAAAACTCATGTTGTCTATCTTTGAACTTGGTAAAAACCC
ACAGGTGCTGCTGCTTATATCTGTGAAGCACTAGCTTATTCTAGGAATGCCTGATTCTTTAATATTGCCTAAATCGGAACCTTTTTCTATGTTGCACACATGGTTTTCAGATGACCCAGCCATCTACA
AGATCTGAATTCTACTGAAAATATCTAGAAATGTGGAAGAGACCTACTTGCACATTCTTAACCTGTATTTGAACACAAAATATCTATACTTCATGCTCCAGCCCAAGCCTATACCCTGTAATAGCATA
CTATTATTGAAATCGCTTGACCGGTCTTGTTCACATAGGCCTCTGGGAGTGATTTGGTTCTTTGCCCTAATGTTTCATTTGACGGTCTCTTTTTGATCAACCAATTTTTCTAAAAGTTCAGTCGAAAG
CTTTTAAGTATAGCTTCCTCCCTTGAAAAAAAATGTAAACTATGACTGCTGAGTGATAAAACACTGTGGTGTGAAAGTGTCATCTTCACTGCCAATCAGGCAAAGACCGGAAAGATTTGCATTTTATT
ATGTCTGTCTTATCATGCAATGGAAATGATGCTTTTTGTAAGTATGCATCTTACCAATGATGTAACGGTTTAATACCTTTGAATGTTTTAATAACCAAGTTGCTGCTGAACTTATACTAAATCAGGGG
ACCAAAAAACTTGCTCTTATCTTCTCAAATTGTATTCTATATCCATTAATGTATCAGTTATCCCAAAGCCTTCAGGTGGAGGGGTTTACCACCTTCCTAGGTCGTTCAACCAGGTTTTGTGAGGAATG
CATTCAAAGTGGCTTTATAAAAGAAGATTTTCTTTAGCAAGAATAATGAGGTCATGTCATTTGTTAATAAGTATCTGTGATAAATCCGTGGTTCAAGGTTAAGCCATTCTGGTATTCTGGTATTAGCA
ACTGTAAATTCTGCCACCTCATACATGGAACAGAGCTTGTGGGATGCTAATAGTTAGTGAAGTATACATGATTTAATTTCTAATAATCTTTATGTTTTCTTTAAGGATGGTGGTGTATTGCTCTTTTT
CAGCTTTATTTTTAAGAGTACAGTCAGGAAACCAACAAGGGGCCTAAGAGTGGCTGCCCCTGCTTGGGACATTACAGCAAGTGAAACAAAGTTAATGTGACAAGCTTTGCTTTGTTATCATTGGTCTT
CACTAGAGGATACCTTTTACATGTACTTCTCTCTTGGATCAAATATGTCTTTAACTGTACATCTCAGTGGCTGGAGGCCATGCCTTTTAAGCATGTGTAAAATTTTTAAAGAAATGAACATACACATA
GTTATTTTAGTAATATTTCCTGAAAGAAAAACCAAATTCTGCTATAAGTCTTGATCTTCAATGAACTTTTAAATAATGCATTTAGCTGGAAAACAAGACTTTCCCAGCTTGTATTACCTAGAAGCGTG
AATGTATAGGATACCTGACTACTAAGACTATATTCTCAGCCCTGCCCTGTCTTTTATTTGCGGGTCTAATCTAATATTAGAATATATTAACCGCTTAAGGCATTGAAGCCATATGGGATGGGGAATGC
ATTTCTTCAGTGTTTCTCCGAGAGACTTTCCATTTCCTTGGAGTTATGGCGGCAAGTAAGTATCATAGTATTAAGAAATTTGCCTAAATCTGAGTTGTGCCTTTCTTTACTCACAAGGCATGGGCTTT
GTCCTGGTGATCAGTTTGTAAGCCTTCTTCCTTCCCAGCTCCTTAATAAAAGCAAAGTGATTGAGTAGGTAATGTTCAAAGTGTCTGCCTGTGTACATGTACTTGTATTGATTATGTAGTTCAGTAAG
ATGTGCCCAAGTCATTTCAGAAAGAAAGACCCTTCAGTTTTGATGCATTTTGCTGAACACTTGGGTAGTGAGTGGGATCCTATCCAGTTGAGGAATGCTTGCAATGCTCATTGAAGGGATTTGCTTTG
GGACTTTGTCATCTTCCAGAAAGGAAACATATTGTATATTTGGCCCAGTGTGATTGATTGCTTTATCTTTGGTAACTTTTACTTGAATGGGATTTGCTGAATTAATGACTATTGAATTTAAAACTAAT
TATGAGTTGACAAATAAATAAAAGGTAGTGTTTATGTCTGAGCTTATTGTGTTTGAGCTAACACCAGGTTACTCAGTAACCATGACCTGCTCCTCCATTTCCATTTATTCTCAACATTAAATAGTTTT
ATCTTGTTGTTGCCAGAAATGCACTTGTGCCAGGTATTGTCCCTGCTGTATGAAAAGCTTCTTGGCAATGAATTCTGTAATAGTGCCCTACATTATGGTTTTCTGGTGGAATTGTTTTAACAGTGACA
ACCCAGGATTTCCAATATATTTTTGTTTTATTGTTATTACCAAAAATTCCACTATGATTGATGTTCAGTGATTTTCTATAGCAACTTTTTTGGTAACTCTTTGGGTTTCTGATTTGTTTTAGCTAAAA
TTTTGGGGATATGATTTGGGTCTTTGATTAATGTCAGCTGAACTTGGATTTCTAGTTCATGAAGAAATCTCTCCCAATACCCATTTATCCTATTTTTAGCAATAATTCGTTAATGATTCCACTTGATT
TTCAGAATATTGTCCTGGTTGATTTTGATTTGACAGCATACATTATGAAATTTGAAAGTAGGTTACCATTTTGAGGCAGTTGGATATAAATTATGTAAATATGTATGATTATGATTTTTATAAATGGC
ATAACATGAGTGTACTAACTACCTTCTATGCTGGCCATGCTACAGATTTTCTGGAGGTATGACAATAGTATTTTTTTATGCTCAGATTAAAAATCAGCTTTTCACCTCTCCAGTTTTTCCAAGTGATA
CTCCCAGTTCTAGAGCAATCTACAGCTGTTTATGTGAGGTGCCCAACACCCATTCATCTCAAGTGCTTCAGTCTTTGGTTTATTTCATGCACTGTGCCTTCAAAATGAAATTTTTAAAAGGGACTTTA
AATGAAGTTGAATAGTAGTTTTTAAAAGTCAATTTGTAATTTATGTGAAATCTAACTGTAATGAGGTCCTTTCTGTTTTTTATATGTAAACAGATCTACTAATCCTGTATAAAAGTTATTTTACGATG
TTTGTCTTTCTTTGTGTTTTGTCTCATAATCTTTTTTCAGATGCAATATGCCGGAAAAAGTTATAGGTCCAGTTTGAAAATTATTTAGTTTTTCTGCCTATGCTAGTGGAAAAATAGTACCAGGATCA
GAATACAGGGTATCACCTATGGAATGTTTCTGTATTTATGAATTGACTCAAAAGAAAGCTTTGTTTCTGAAATCGCATTATGTAGTAGCCACAGTTTTCTGTTTGTAGCTCAGCTAGATTGTTATATA
TGTTCAATCATTTCACAATAACAACACAAAACTGGTCATTGAAAGGTTTTTATGTACGCATTTTAAACTTGTTCGTTAAAAATTTGGTCCTTTTTCCAGGTGAGGCCCAGTTAGAATAATGTGTCCCG
GCACTTTTAGGCACAGCAAGGATGAATTCAATATCCCCTTTTCACTTAGCAACAATGTGTTACTTCTACCCTAATAGGAATTGGGAAAGCAAAGTTGTATGAGAAACAGACTCTGCTGATAAAGTACT
CATAGTCCAGACCAGAGAAATATAAATGGAAATAGGTTATATTTCAATAGTGATTGGTTCATCTAAAAGTCTCTGCTGTAAAGGAAATAAAGCATAGAGGTTTGAGCATGGACTTTGGAGTTGGACCA
ATCTGTGACTGATTCTTCGTTCTGCTACTTGCTTCCAATGTGACCTTGTACAAGTTTCTTGACATTCTCTGAGCCTCAGTTTCTCTACTGGTTGAATAATCCTTGATAGGATTGCAGTGGAAAATTAA
ATGAAATAATGTTAGCAAAGGTCCCAACATAATATTTGACTTGGAATTGAATGCCCATGGTAACCAGCATCATTTTCCTTCATGTGATGTCTTCTTATGCCTTTGAAAGAAAGTTACTTTATCAAATG
TATAAATAAAGATCTGTTTATAGGTGATCTTTTTAATTTAGAAGAAATTCTGAGACACAAATAAAAAAAGAAATTTTTTATTATGTGGTTCAATAGATTGTCTAAAGCATGGCAGTAAAGTTTTAATT
ATGCCAAGATGCTTCATATTTGTTTTTAAATGAAATTAAGTTGTATTTATGCTTCTTTAGTGAAAACAACGTTACTTAACTGCTACAGGAAGTGTGAATAGTGATAACAGTTCTTTTTCTCTCAGTGT
TTGAAATATTTTCCTGAATTTTCTTAGTTTTCTCATACCTGAATCAAGAACCCTTTTGGTTTGTTTCATAAACAGTAATCTAGTTATTATGTTCAGCTTTTCAGATTTATAATAGCTGATTGTTCTCA
GCAAATTAAACATGATGGTCAACGCTAA

hide sequence


Protein RefSeqs	NP_001186704	(Get FASTA)	NCBI Sequence Viewer
	NP_001295	(Get FASTA)	NCBI Sequence Viewer
GenBank Protein	AAC51775	(Get FASTA)	NCBI Sequence Viewer
	AAH45549	(Get FASTA)	NCBI Sequence Viewer
	AAH45624	(Get FASTA)	NCBI Sequence Viewer
	AAH51702	(Get FASTA)	NCBI Sequence Viewer
	BAA33370	(Get FASTA)	NCBI Sequence Viewer
	BAH13725	(Get FASTA)	NCBI Sequence Viewer
	BAH13829	(Get FASTA)	NCBI Sequence Viewer
	BAH14780	(Get FASTA)	NCBI Sequence Viewer
	EAW51227	(Get FASTA)	NCBI Sequence Viewer
	EAW51228	(Get FASTA)	NCBI Sequence Viewer
Ensembl Protein	ENSP00000225719
	ENSP00000225719.4
	ENSP00000444443
	ENSP00000444443.2
GenBank Protein	O75976	(Get FASTA)	NCBI Sequence Viewer

RefSeq Acc Id:	NP_001295 ⟸ NM_001304
- Peptide Label:	isoform 1 precursor
- UniProtKB:	Q86SH9 (UniProtKB/Swiss-Prot), O15377 (UniProtKB/Swiss-Prot), F5GZH6 (UniProtKB/Swiss-Prot), B7ZAU4 (UniProtKB/Swiss-Prot), B7Z7T9 (UniProtKB/Swiss-Prot), Q86XE6 (UniProtKB/Swiss-Prot), O75976 (UniProtKB/Swiss-Prot)
- Sequence:	show sequence MASGRDERPPWRLGRLLLLMCLLLLGSSARAAHIKKAEATTTTTSAGAEAAEGQFDRYYHEEELESALREAAAAGLPGLARLFSIGRSVEGRPLWVLRLTAGLGSLIPEGDAGPDAAGPDAAGPLLPG RPQVKLVGNMHGDETVSRQVLIYLARELAAGYRRGDPRLVRLLNTTDVYLLPSLNPDGFERAREGDCGFGDGGPSGASGRDNSRGRDLNRSFPDQFSTGEPPALDEVPEVRALIEWIRRNKFVLSGNL HGGSVVASYPFDDSPEHKATGIYSKTSDDEVFKYLAKAYASNHPIMKTGEPHCPGDEDETFKDGITNGAHWYDVEGGMQDYNYVWANCFEITLELSCCKYPPASQLRQEWENNRESLITLIEKVHIGV KGFVKDSITGSGLENATISVAGINHNITTGRFGDFYRLLVPGTYNLTVVLTGYMPLTVTNVVVKEGPATEVDFSLRPTVTSVIPDTTEAVSTASTVAIPNILSGTSSSYQPIQPKDFHHHHFPDMEIF LRRFANEYPNITRLYSLGKSVESRELYVMEISDNPGVHEPGEPEFKYIGNMHGNEVVGRELLLNLIEYLCKNFGTDPEVTDLVHNTRIHLMPSMNPDGYEKSQEGDSISVIGRNNSNNFDLNRNFPDQ FVQITDPTQPETIAVMSWMKSYPFVLSANLHGGSLVVNYPFDDDEQGLATYSKSPDDAVFQQIALSYSKENSQMFQGRPCKNMYPNEYFPHGITNGASWYNVPGGMQDWNYLQTNCFEVTIELGCVKY PLEKELPNFWEQNRRSLIQFMKQVHQGVRGFVLDATDGRGILNATISVAEINHPVTTYKTGDYWRLLVPGTYKITASARGYNPVTKNVTVKSEGAIQVNFTLVRSSTDSNNESKKGKGASSSTNDASD PTTKEFETLIKDLSAENGLESLMLRSSSNLALALYRYHSYKDLSEFLRGLVMNYPHITNLTNLGQSTEYRHIWSLEISNKPNVSEPEEPKIRFVAGIHGNAPVGTELLLALAEFLCLNYKKNPAVTQL VDRTRIVIVPSLNPDGRERAQEKDCTSKIGQTNARGKDLDTDFTNNASQPETKAIIENLIQKQDFSLSVALDGGSMLVTYPYDKPVQTVENKETLKHLASLYANNHPSMHMGQPSCPNKSDENIPGGV MRGAEWHSHLGSMKDYSVTYGHCPEITVYTSCCYFPSAARLPSLWADNKRSLLSMLVEVHKGVHGFVKDKTGKPISKAVIVLNEGIKVQTKEGGYFHVLLAPGVHNIIAIADGYQQQHSQVFVHHDAA SSVVIVFDTDNRIFGLPRELVVTVSGATMSALILTACIIWCICSIKSNRHKDGFHRLRQHHDEYEDEIRMMSTGSKKSLLSHEFQDETDTEEETLYSSKH hide sequence

RefSeq Acc Id:	NP_001186704 ⟸ NM_001199775
- Peptide Label:	isoform 2
- UniProtKB:	O75976 (UniProtKB/Swiss-Prot)
- Sequence:	show sequence MRFVLSGNLHGGSVVASYPFDDSPEHKATGIYSKTSDDEVFKYLAKAYASNHPIMKTGEPHCPGDEDETFKDGITNGAHWYDVEGGMQDYNYVWANCFEITLELSCCKYPPASQLRQEWENNRESLIT LIEKVHIGVKGFVKDSITGSGLENATISVAGINHNITTGRFGDFYRLLVPGTYNLTVVLTGYMPLTVTNVVVKEGPATEVDFSLRPTVTSVIPDTTEAVSTASTVAIPNILSGTSSSYQPIQPKDFHH HHFPDMEIFLRRFANEYPNITRLYSLGKSVESRELYVMEISDNPGVHEPGEPEFKYIGNMHGNEVVGRELLLNLIEYLCKNFGTDPEVTDLVHNTRIHLMPSMNPDGYEKSQEGDSISVIGRNNSNNF DLNRNFPDQFVQITDPTQPETIAVMSWMKSYPFVLSANLHGGSLVVNYPFDDDEQGLATYSKSPDDAVFQQIALSYSKENSQMFQGRPCKNMYPNEYFPHGITNGASWYNVPGGMQDWNYLQTNCFEV TIELGCVKYPLEKELPNFWEQNRRSLIQFMKQVHQGVRGFVLDATDGRGILNATISVAEINHPVTTYKTGDYWRLLVPGTYKITASARGYNPVTKNVTVKSEGAIQVNFTLVRSSTDSNNESKKGKGA SSSTNDASDPTTKEFETLIKDLSAENGLESLMLRSSSNLALALYRYHSYKDLSEFLRGLVMNYPHITNLTNLGQSTEYRHIWSLEISNKPNVSEPEEPKIRFVAGIHGNAPVGTELLLALAEFLCLNY KKNPAVTQLVDRTRIVIVPSLNPDGRERAQEKDCTSKIGQTNARGKDLDTDFTNNASQPETKAIIENLIQKQDFSLSVALDGGSMLVTYPYDKPVQTVENKETLKHLASLYANNHPSMHMGQPSCPNK SDENIPGGVMRGAEWHSHLGSMKDYSVTYGHCPEITVYTSCCYFPSAARLPSLWADNKRSLLSMLVEVHKGVHGFVKDKTGKPISKAVIVLNEGIKVQTKEGGYFHVLLAPGVHNIIAIADGYQQQHS QVFVHHDAASSVVIVFDTDNRIFGLPRELVVTVSGATMSALILTACIIWCICSIKSNRHKDGFHRLRQHHDEYEDEIRMMSTGSKKSLLSHEFQDETDTEEETLYSSKH hide sequence

Ensembl Acc Id:

ENSP00000444443 ⟸ ENST00000543464

Ensembl Acc Id:

ENSP00000463763 ⟸ ENST00000584221

Ensembl Acc Id:

ENSP00000466049 ⟸ ENST00000584050

Protein Domains

Peptidase M14 Peptidase M14 carboxypeptidase A

Name	Modeler	Protein Id	AA Range	Protein Structure
AF-O75976-F1-model_v2	AlphaFold	O75976	1-1380	view protein structure

RGD ID:

6793890

Promoter ID:

HG_KWN:25653

Type:

CpG-Island

SO ACC ID:

SO:0000170

Source:

MPROMDB

Tissues & Cell Lines:

CD4+TCell, CD4+TCell_12Hour, CD4+TCell_2Hour, HeLa_S3, Jurkat, K562, Lymphoblastoid, NB4

Transcripts:

OTTHUMT00000256214

Position:

Human Assembly	Chr	Position (strand)	Source
Build 36	17	25,729,879 - 25,730,379 (+)	MPROMDB

RGD ID:

7234509

Promoter ID:

EPDNEW_H23001

Type:

initiation region

Name:

CPD_1

Description:

carboxypeptidase D

SO ACC ID:

SO:0000170

Source:

EPDNEW (Eukaryotic Promoter Database, http://epd.vital-it.ch/)

Experiment Methods:

Single-end sequencing.

Position:

Human Assembly	Chr	Position (strand)	Source
GRCh38	17	30,378,936 - 30,378,996	EPDNEW

Database	Acc Id	Source(s)
COSMIC	CPD	COSMIC
Ensembl Genes	ENSG00000108582	Ensembl, ENTREZGENE, UniProtKB/Swiss-Prot
Ensembl Transcript	ENST00000225719	ENTREZGENE
	ENST00000225719.9	UniProtKB/Swiss-Prot
	ENST00000543464	ENTREZGENE
	ENST00000543464.6	UniProtKB/Swiss-Prot
Gene3D-CATH	Carboxypeptidase-like, regulatory domain	UniProtKB/Swiss-Prot
	Zn peptidases	UniProtKB/Swiss-Prot
GTEx	ENSG00000108582	GTEx
HGNC ID	HGNC:2301	ENTREZGENE
Human Proteome Map	CPD	Human Proteome Map
InterPro	CarboxyPept-like_regulatory	UniProtKB/Swiss-Prot
	M14_CPD_II	UniProtKB/Swiss-Prot
	M14_CPD_III	UniProtKB/Swiss-Prot
	Peptidase_M14	UniProtKB/Swiss-Prot
	Peptidase_M14_domain	UniProtKB/Swiss-Prot
KEGG Report	hsa:1362	UniProtKB/Swiss-Prot
NCBI Gene	1362	ENTREZGENE
OMIM	603102	OMIM
PANTHER	PROTEASE M14 CARBOXYPEPTIDASE	UniProtKB/Swiss-Prot
	PTHR11532:SF73	UniProtKB/Swiss-Prot
Pfam	CarboxypepD_reg	UniProtKB/Swiss-Prot
	Peptidase_M14	UniProtKB/Swiss-Prot
PharmGKB	PA26823	PharmGKB
PRINTS	CRBOXYPTASEA	UniProtKB/Swiss-Prot
PROSITE	CARBOXYPEPT_ZN_1	UniProtKB/Swiss-Prot
	CARBOXYPEPT_ZN_2	UniProtKB/Swiss-Prot
	PEPTIDASE_M14	UniProtKB/Swiss-Prot
SMART	Zn_pept	UniProtKB/Swiss-Prot
Superfamily-SCOP	SSF49464	UniProtKB/Swiss-Prot
	Zn-dependent exopeptidases	UniProtKB/Swiss-Prot
UniProt	B7Z7T9	ENTREZGENE
	B7ZAU4	ENTREZGENE
	CBPD_HUMAN	UniProtKB/Swiss-Prot
	F5GZH6	ENTREZGENE
	J3QQJ4_HUMAN	UniProtKB/TrEMBL
	J3QRJ9_HUMAN	UniProtKB/TrEMBL
	K7ELF0_HUMAN	UniProtKB/TrEMBL
	O15377	ENTREZGENE
	O75976	ENTREZGENE
	Q86SH9	ENTREZGENE
	Q86XE6	ENTREZGENE
UniProt Secondary	B7Z7T9	UniProtKB/Swiss-Prot
	B7ZAU4	UniProtKB/Swiss-Prot
	F5GZH6	UniProtKB/Swiss-Prot
	O15377	UniProtKB/Swiss-Prot
	Q86SH9	UniProtKB/Swiss-Prot
	Q86XE6	UniProtKB/Swiss-Prot

Gene Annotator (Functional Annotation) unavailable	Gene Annotator (Annotation Distribution) unavailable	Variant Visualizer (Genomic Variants) unavailable


InterViewer (Protein-Protein Interactions) unavailable	Gviewer (Genome Viewer) unavailable	Variant Visualizer (Damaging Variants) unavailable


Gene Annotator (Annotation Comparison) unavailable	OLGA (Gene List Generator) unavailable
		Excel (Download)

MOET (Multi-Ontology Enrichement) unavailable	GOLF (Gene-Ortholog Location Finder) unavailable

Send us a Message

Imported Disease Annotations - ClinVar